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Jadesada Palasuk 
SYNTHESIS, CHARACTERIZATION AND MATRIX METALLOPROTEINASE 
INHIBITION OF DOXYCYCLINE MODIFIED DENTAL ADHESIVES 
 
The biodegradation of the hybrid layer of dental restorations is due in part to the 
degradation of the demineralized collagen by matrix metalloproteinases (MMPs). During 
the bonding procedure, phosphoric acid/acidic primers activate MMPs that degrade 
denuded type I collagen. As a result, the hybrid layer loses its integrity overtime, leading 
to the failure of the resin composite restoration. This study aimed to evaluate doxycycline 
(DOX) for its effects on preventing the degradation of the hybrid layer through the 
modification of the dental adhesive with aluminosilicate clay nanotubes (HNT) loaded 
with doxycycline.  
Doxycycline was encapsulated into HNT at three distinct concentrations (10%, 
20% and 30% DOX, w/v). The increases in the concentration of doxycycline significantly 
increased the amount of doxycycline that was encapsulated into HNT and the drug 
loading into the HNT. Conversely, the encapsulation efficiency was significantly 
decreased with the increases in concentration of doxycycline. The modified adhesives 
were fabricated by incorporation of DOX-encapsulated HNT into a commercially 
available dental adhesive (Adper Scotchbond Multi-Purpose, SBMP). The degree of 
conversion (DC), Knoop microhardness, doxycycline release profiles, the biological 
activity (antibacterial and anti-MMP activity), and cytocompatibility of the modified 
adhesives were investigated. There were no statistically significant differences (p > 0.05) 
in DC and Knoop microhardness compared to the control (SBMP). None of the adhesive 
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eluates was cytotoxic to the human dental pulp stem cells. Although higher 
concentrations of doxycycline led to a higher release of doxycycline from the modified 
adhesives, the differences were not significant (p = 0.259) among the groups (10%, 20% 
and 30% DOX). A significant growth inhibition of S. mutans and L. casei by direct 
contact illustrated successful encapsulation of doxycycline into the modified adhesives. 
Doxycycline released from the modified adhesives did not inhibit the growth of both 
cariogenic bacteria but inhibited MMP-1 activity. The results suggested that 
subantimicrobial levels of doxycycline were gradually released. The immediate 
microtensile bond strengths were not significantly different from those of the control 
(SBMP), suggesting no negative effect of doxycycline on dentin bonding (only 10% 
DOX were investigated). The long-term resin-dentin bond durability should be evaluated.  
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INTRODUCTION  
According to a report of the World Health Organization (WHO), dental caries is 
one of the world’s major diseases affecting 60–90% of children and most adults (Petersen 
and Lennon, 2004). Resin composites have become one of the materials of choice for 
direct restoration because of superior esthetics and minimally invasive preparations, 
compared to traditionally used amalgam restorations with mercury concerns. However, 
resin composite restorations have an average lifetime of only 5.7 years (Liu et al., 2011) 
and an average annual failure rate of 2.2% (Manhart et al., 2004; Mjor et al., 2000). 
Replacement of defective dental restorations costs approximately five billion dollars per 
year in the US (Jokstad et al., 2001). Secondary caries that develops at the margin of the 
restoration is the primary reason for restoration replacement (Mjor et al., 2000). 
Kermanshahi et al. reported that degradation of the hybrid layer of a dental restoration 
increased bacterial microleakage (Kermanshahi et al., 2010). As a consequence, the 
degradation of the hybrid layer may contribute to recurrent caries or failure of the 
restorations. Since the hybrid layer of resin-enamel bonding is more durable than that of 
resin-dentin bonding (Loguercio et al., 2008), this study focused mainly on the resin-
dentin bonding and the degradation of the hybrid layer at the resin-dentin interface.  
Anatomy of teeth 
Enamel 
Enamel is the hard-mineralized tissue that covers the crown of teeth. Enamel is 
formed by ameloblasts starting at the dentin-enamel junction (DEJ) and proceeding 
outward to the tooth surface. Enamel covers the anatomic crowns of teeth and varies in 
thickness in different areas and is the hardest substance of the human body. Enamel is a 
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highly mineralized crystalline structure consisting of approximately 95–98% by weight 
and 90–92% by volume inorganic components. Hydroxyapatite crystal makes up the 
highest amount of the mineral content in enamel. The remaining components of enamel 
are organic matrix and water of approximately 1–2% and 4% by weight, respectively. 
The organic matrices of enamel are mainly amelogenins and enamelins that are resorbed 
during tooth maturation (Sakaguchi and Powers, 2012). Enamel is structurally arranged 
as prisms or rods of approximately 5 µm in diameter (Roberson et al., 2006; Sakaguchi 
and Powers, 2012). The numbers of rods are approximately 5 million for mandibular 
incisors and 12 million for maxillary molars. Enamel rods generally orient 
perpendicularly to the DEJ and the tooth surface except in the cervical region where they 
are aligned outward in a slightly apical direction (Roberson et al., 2006). 
Dentin-Pulp Complex 
The dentin and the dental pulp are considered as a biologic entity named the 
“dentin-pulp complex” because of their common mesenchymal origin, conjugated 
evolution, and highly related interactions (Vitalariu et al., 2005). Dentin is a mineralized 
connective tissue formed by odontoblasts. The body of odontoblasts is located in the pulp 
chamber but their cytoplasmic processes are extended toward the dentinal tubules. 
Therefore, dentin is considered a living tissue and can respond to external stimuli (i.e., 
caries, trauma) creating different forms of dentin such as secondary, reparative or tertiary, 
and sclerotic dentin. 
Mature dentin contains 50% inorganic structures, 30% organic structures, and 
20% water by weight. Like enamel, the inorganic component is primarily hydroxyapatite 
crystals. The organic components are mainly type I collagen and noncollagenous proteins 
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such as dentin matrix protein 1 (DMP 1), dentin phosphoprotein (DPP), and dentin 
sialoprotein (DSP) (Mazzoni et al., 2009). One of the main structures of dentin is dentinal 
tubules that are small canals created by odontoblasts during dentin formation or 
dentinogenesis. Dentinal tubules extend from the DEJ to the pulp chamber covering the 
entire width of dentin. Each dentinal tubule also contains the cytoplasmic extension of 
odontoblasts that extends approximately one third of the dentin thickness (Goracci et al., 
1999). In addition to main tubules, dentin also contains a branching and anastomosing 
system (Mjor and Nordahl, 1996). The density and number of dentinal tubules and 
branching are different in different locations. The number of branches of dentinal tubules 
was particularly abundant in locations where the density of tubules was low. Three types 
of branches have been identified: major branches (0.5–1 µm in diameter), fine branches 
(0.3–0.7 µm in diameter), and microbranches (25–200 nm in diameter). 
Dentin is typically pale yellow and is slightly harder than bone. There are two 
main types of dentin: intertubular and peritubular dentin (Summitt et al., 2006). 
Intertubular dentin is the main structural component of dentin. It is the hydroxyapatite 
crystal embedded in type I collagen matrix. Peritubular dentin is densely packed 
hydroxyapatite crystals that wrap around dentinal tubule walls. After primary dentin is 
formed, mineral deposition of dentin gradually decreases the tubule lumen of dentin. The 
rate of deposition may increase in response to external stimuli such as caries or trauma. 
Cementum 
Cementum is a hard-mineralized tissue secreted by cementoblasts and is present 
on the surface of the roots. By weight, cementum consists of 45–50% inorganic 
components that are primarily hydroxyapatite crystals and 55–50% organic matrix and 
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water. The organic contents are mainly type I collagen. Cementum is classified into two 
main types: cellular and acelluar cementum (Gonçalves et al., 2005). Acellular cementum 
is located on the coronal half of the root surface. It does not contain cementocytes in its 
structure. Cellular cementum is present predominantly on the apical half of root surfaces 
and contains cementocytes embedded in a collagenous matrix of intrinsic collagen fibers. 
Cellular cementum plays a crucial role in adaptive response to external stimuli (i.e. repair 
process) and maintaining the tooth in proper position. Thickness of cementum can 
increase in response to occlusal wear and passive eruption of the root (Roberson et al., 
2006). 
Bonding to dental substrates 
Bonding mechanism 
Adhesive dentistry has evolved since Buonocore first introduced orthophosphoric 
acid-etching to improve the adhesion of acrylic resin to enamel in 1955 (Buonocore, 
1955). Nevertheless, the basic principle of adhesion to tooth substrate remains 
unchanged. The bonding to tooth substrate is based on an exchange process that involves 
the removal of mineral content from dental hard tissue followed by the application and 
infiltration of an adhesive resin/dentin bonding agent. This results in micromechanical 
interlocking that is believed to be a prerequisite for good bonding in clinical settings (Van 
Meerbeek et al., 2003). The micromechanical interlocking was first demonstrated in 1982 
by Nakabayashi et al. (Nakabayashi et al., 1982). This process is referred to as 
“hybridization” or the formation of the hybrid layer (De Munck et al., 2005; Wang and 
Spencer, 2003). The hybrid layer is the zone that resin monomers flow and polymerize 
into the acid-etched dentin creating a micromechanical interlocking for resin-dentin 
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bonding. In the hybrid layer, demineralized collagen matrix (type I collagen) serves as a 
scaffold for the infiltration of hydrophilic resin monomers. Wang et al. reported that the 
quality of the hybrid layer that unites the resin composite with the underlying dentin is 
directly related to the durability of the resin-dentin bond (Wang and Spencer, 2003). 
Ideally, the adhesive resin should completely infiltrate into the space generated by the 
removal of mineral by acid etching. If the creation of the hybrid layer is imperfect, it will 
lead to limited resin-dentin bond durability and severely shortens the lifespan of a resin 
composite restoration (Liu et al., 2011). 
Current adhesive systems can be classified into two major categories based on 
two distinct mechanisms: removing (etch-and-rinse adhesives) and modifying smear 
layer (self-etch adhesives) (Breschi et al., 2008). 
Etch-and-rinse adhesive systems 
The etch-and-rinse adhesives involve simultaneous enamel and dentin etching 
using 30–40% phosphoric acid (pH ~ 0.5–1) for a predetermined period of time (15–30 
seconds). Subsequently, the etched enamel and dentin are rinsed off, and a primer (an 
adhesion promoting agent) and eventually an adhesive resin are applied either separately 
(three-step etch-and-rinse adhesives) or in combination (two-step etch-and-rinse 
adhesives). The role of the primer is to remove water that occupies interfibrillar spaces 
after etching and rinsing, and to facilitate resin infiltration by increasing the 
hydrophobicity of the dentin. Generally, primers are composed of hydrophilic monomers 
dissolved in an appropriate solvent. The hydrophilic monomers include 2-hydroxyethyl 
methacrylate (HEMA) and dipentaerythritol pentaacrylate monophosphate (PENTA). The 
solvents are ethanol, water, acetone or a combination of these solvents. After the 
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application of primer, the solvent is removed by air-drying, and the more hydrophobic 
dentin is copolymerized with the adhesive resin creating a 5–8 µm thick hybrid layer. 
Since a rinsing step is required for etch-and-rinse adhesives, the smear layer, the smear 
plugs, and the demineralized inorganic component of dentin will not be part of the hybrid 
layer after bonding (Pashley et al., 2011).  
 Initially, the etch-and-rinse adhesive was introduced as a dry bonding technique 
where the cavity wall was air-dried after acid etching and rinsing until the enamel margin 
appeared as a chalky-like color. This results in a relatively dry enamel surface that is 
needy for bonding. If the demineralized dentin is over-dried, the interfibrillar spaces of 
the collagen network that are essential for resin infiltration will collapse. As a 
consequence, the resin-enamel bond strength is high but the resin-dentin bond strength is 
very low (Pashley et al., 2011). The other shortcomings associated with the dry bonding 
technique are dentin hypersensitivity, microleakage, and secondary caries (Pashley et al., 
2011). 
To overcome the limitation of the dry bonding technique, Kanca introduced the 
concept of wet bonding (Kanca, 1992). He found that water is an excellent rewetting 
agent. When the demineralized dentin is moist prior to the application of primer and 
adhesive resins, the resin-dentin bond strength is improved with less post-operative 
sensitivity (Pashley et al., 2011).  
Both clinical and in vitro studies showed that the three-step etch-and-rinse 
adhesive system provided a superior outcome in terms of effectiveness of bonding 
compared to other systems, especially the one-step self-etch adhesive systems (De Munck 
et al., 2003; De Munck et al., 2005; Peumans et al., 2005; Rosa et al., 2015; Van 
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Meerbeek et al., 2010). Therefore, the three-step etch-and-rinse adhesive is considered a 
gold standard for dental adhesion and is often used as a control to compare the 
performance of new adhesives (Van Meerbeek et al., 2010).  
Self-etch adhesive systems 
Unlike etch-and-rinse adhesives, self-etch adhesives do not require a separate 
etching step because the acidic primers of self-etch adhesives diffuse into the smear layer, 
etching and priming the dentin simultaneously. Since no rinsing is required, the smear 
layer is partially dissolved and later copolymerized with the adhesive resin, becoming 
part of the hybrid layer (Koibuchi et al., 2001; Prati et al., 1998; Tay et al., 2000). One of 
the main advantages of this approach is fewer incidences of post-operative sensitivity, 
compared to the etch-and-rinse adhesives, due to less aggressive acid etching of dentin 
and the presence of a partially dissolved smear layer that obstructs dentinal tubules. 
Generally, hybrid layers created by self-etch adhesives range from 1–2 µm in thickness, 
depending upon the acidity of the monomers used (Van Meerbeek et al., 2011). It has 
been reported that the number of resin tags, not the length of resin tags or thickness of the 
hybrid layer, plays a major role in dentin bonding (Lohbauer et al., 2008; Yoshiyama et 
al., 1995).  
Based on the pH or intensity of acid demineralization, self-etch adhesives are 
subdivided into four types: ultra mild (pH > 2.5), mild (pH ~ 2), intermediate (pH = 1–2) 
and strong (pH < 1) (Van Meerbeek et al., 2011). Like etch-and-rinse adhesives, strong 
self-etch adhesives completely dissolve the hydroxyapatite from dentin but unlike etch-
and-rinse adhesives, the hydroxyapatite is not rinsed off. This results in relatively deep 
dentin hybridization several micrometers thick, and the dissolved calcium and phosphate 
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that remain in the demineralized dentin are not stable in an aqueous environment. As a 
result, the resin-dentin bond is compromised with less hydrolytic stability (Van Meerbeek 
et al., 2011).  
On the other hand, the mild self-etch adhesives partially demineralize dentin 
creating submicron-thick hybrid layers, in which substantial amount of hydroxyapatite 
remains around exposed collagen. Generally, the acidic monomers of self-etch primers 
and adhesives are esters from the reaction of a bivalent alcohol with methacrylic acid and 
phosphoric/carboxylic acid derivatives (Yoshida et al., 2004). Moreover, self-etch 
adhesives also contain specific functional monomers that facilitate chemical bonding to 
the remaining hydroxyapatite.  
The chemical interaction between dentin and self-etch adhesives occurs through 
the ionic bond formed between the calcium in hydroxyapatite and the 
carboxylic/phosphate group of the functional monomers in the acidic primer [i.e., 10-
methacryloxydecyl dihydrogen phosphate (10-MDP), 4-methacryloyloxyethyl trimellitic 
acid (4-MET), and 2-methacryloxyethyl phenyl hydrogen phosphate (phenyl-P) (De 
Munck et al., 2005; Lohbauer et al., 2008; Yoshida et al., 2004)]. According to the 
Adhesion-Decalcification (AD) concept, the functional monomers first chemically or 
ionically bond to calcium in the hydroxyapatite. This step occurs together with the release 
of phosphate (PO43−) and hydroxide (OH−) into the adhesive suspension. This ionic bond 
may either decompose and demineralize the tooth surface, or remain stable and 
chemically bond with calcium depending on the stability of the resulting calcium-
monomer complex (Van Landuyt et al., 2008). Yoshida et al chemically characterized the 
bond formation and the stability of the bond of three common functional monomers (10-
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MDP, 4-MET and phenyl-P) with synthetic hydroxyapatite using x-ray photoelectron 
spectroscopy (XPS) and atomic absorption spectrophotometry, and the interactions of 
these monomers with dentin ultra-morphologically using transmission electron 
microscopy (Yoshida et al., 2004). They found that the chemical bond created by the 10-
MDP monomer is very effective and stable as confirmed by the lower dissolution rate of 
its calcium salt in water. The bonding potential of 4-MET was substantially lower. The 
monomer phenyl-P and its bonding to hydroxyapatite did not appear to be hydrolytically 
stable. The results suggest additional roles of functional monomers in acidic primers that 
contribute to their adhesive potential to dentin other than micromechanical interlocking 
(Yoshida et al., 2004). 
The self-etch adhesives are typically supplied as two-step or one-step adhesives 
depending on whether the self-etch primer and the adhesive are provided separately or 
supplied in one bottle. One-step self-etch adhesives are subdivided into single component 
(all-in-one) and two components that need to be mixed prior to use. The single 
component self-etch adhesives provide several advantages including fewer technical 
demands and shorter application time. However, this adhesive is a combination of 
hydrophilic and hydrophobic monomers that has been reported to have shortcomings 
including reduced immediate bonding strength, increased nanoleakage, high water 
sorption (due to the high hydrophillic HEMA content), limited bonding durability, phase 
separation, formation of water bubbles when the solvent starts to evaporate, and poor 
clinical performance (Van Meerbeek et al., 2011). 
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Degradation of hybrid layer 
The ultimate goal of resin-dentin bonding is to create a complete resin infiltration 
into the demineralized dentin matrix. However, incomplete infiltration of resin monomers 
into demineralized dentin normally occurs and possibly contributes to the formation of 
less durable resin-dentin bonds compared to bonding to enamel (Liu et al., 2011). It has 
been suggested that resin-dentin bonds are degraded extensively leading to restoration 
failure (Tjaderhane et al., 2013b). The degradation of resin-dentin bonds can be observed 
by the loss of bond strength to dentin and increased nanoleakage at the hybrid layer.  
The loss of dentin bond strength after aging (i.e., 6–12 months) has been reported 
in many studies. Bond strength tests are most commonly used to evaluate the 
effectiveness of the resin-dentin bond. The rationale behind these tests is that the stronger 
the adhesion between resin and dentin, the better it will resist the stress during function. 
The microtensile bond strength test is the most widely used bond strength testing method 
because of the following reasons: (1) this test is more sensitive to artificial aging than the 
other tests [i.e., fracture toughness, and nanoleakage tests]; (2) multiple microtensile 
beams can be obtained from one tooth; and (3) unlike the microtest methods (shear bond 
strength test), the microtensile bond strength test creates more uniform stress distribution 
at the interface (De Munck et al., 2005).  
It was reported that the microtensile bond strength significantly decreases with 
increasing water storage time (De Munck et al., 2012). The duration and technique of 
aging varied among studies (i.e., aging by water storage, thermocycling, occlusal loading 
and in vivo degradation studies). The most commonly used artificial aging technique is 
storage in water or artificial saliva at 37°C for a period of time. This period ranges from a 
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few months (Armstrong et al., 2001; Armstrong et al., 2003; Shono et al., 1999) to 3–4 
years (De Munck et al., 2003; Reis et al., 2008) or longer (Armstrong et al., 2004; 
Fukushima et al., 2001). Some studies reported a significant reduction in bond strength 
even after a short period of aging (Armstrong et al., 2001; Armstrong et al., 2003; De 
Munck et al., 2003). The decrease in bond strength could be attributed to the degradation 
of hybrid layer.  
Nanoleakage is defined as the diffusion of nanometer-sized molecules (i.e., silver 
nitrate) within adhesive resin, demineralized dentin, or the hybrid layer in the absence of 
gap formation (Sano et al., 1995a; Sano et al., 1995b). The term nanoleakage was used 
because the spaces that allow the leakage are approximately 20–200 nm compared to 10–
20 µm for microleakage (Sano, 2006). The spaces of nanoleakage are too small for 
bacterial penetration. However, they are large enough for the penetration of water and 
enzymes. Therefore, nanoleakage could be a channel for degradation of the hybrid layer 
(Sano, 2006). There are two types of nanoleakage: reticular and spotted types (Tay et al., 
2002). The reticular type is related to incomplete resin infiltration and degradation of the 
hybrid layer, while the spotted type results from the adsorption of silver nitrate by 
hydrophilic and/or acidic functional groups of the adhesive resin (Sano, 2006; Tay et al., 
2002; Tay et al., 2004). As the degradation occurs at the hybrid layer, reticular patterns of 
nanoleakage are observed, especially at the bottom of the hybrid layer (Breschi et al., 
2010; Carrilho et al., 2007; Talungchit et al., 2014).   
Nanoleakage indicates incomplete resin infiltration. Theoretically, discrepancies 
between the depths of demineralization and resin infiltration should not be observed, 
especially when using self-etch adhesives because they demineralize dentin and 
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simultaneously replace it with resin monomers. However, several studies demonstrated 
nanoleakage at the bottom of the hybrid layer even with self-etch adhesives (Carvalho et 
al., 2005; Wang and Spencer, 2005; Yuan et al., 2007). It is speculated that this is a 
manifestation of incomplete resin infiltration into the demineralized collagen network 
(Carvalho et al., 2005; Yuan et al., 2007) or continuous etching (Wang and Spencer, 
2005). Moreover, the excess water in dentin and/or dentinal tubules also inhibits 
polymerization of acidic monomer. As a result, the acidic monomer will continue to 
demineralize the surrounding dentin and the nanoleakage could be observed (Wang and 
Spencer, 2005).  
The demineralized dentin that is not fully infiltrated by resin monomers is 
normally occupied by water that may contribute to the deterioration of the hybrid layer 
through two main mechanisms.  
Degradation of adhesive resin by esterases and hydrolysis   
Resin based dental materials (i.e., resin composite, adhesive resin) generally 
consist of inorganic filler, polymer matrix, and a silane coupling agent; the latter is used 
to improve the bonding between fillers and the polymer matrix. The most commonly used 
polymer matrices in dentistry are methacrylate-based resins (Figure 1) that contain ester 
linkages such as bisphenol A diglycidyl ether diemthacrylate (Bis-GMA), bisphenol A 
polyethylene glycol dimethacrylate (Bis-EMA), ethylene glycol dimethacrylate 
(EGDMA), urethane dimethacrylate (UDMA), triethylene glycol dimethacrylate 
(TEGDMA), and 2-hydroxyethyl methacrylate (HEMA). The ester linkages are 
vulnerable to hydrolysis by esterases in the oral cavity. When the ester linkages of 
adhesive resin breakdown, the parent molecules are converted into carboxylic acid and 
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alcohol. Figure 2 illustrates the biodegradation of the dental monomer Bis-GMA to Bis-
hydroxy-propoxy-phenyl-propane (BisHPP) and methacrylic acid (MA). Figure 3 
demonstrates the biodegradation of the dental monomer TEGDMA to Triethylene glycol 
(TEG) and methacrylic acid (MA). 
Hydrolysis is a chemical reaction that involves the breakdown of chemical bonds 
with water. Hydrolysis can be catalyzed by enzymes (i.e., esterases) and this process is 
called biodegradation. Studies reported that human saliva contains esterases that can 
degrade resin composite and adhesive resin (Jaffer et al., 2002). These enzymes may 
originate from salivary glands, microorganisms, inflammatory responses, and human 
cells such as human gingival/pulp fibroblasts (Gregson et al., 2009; Jaffer et al., 2002) 
and mononuclear phagocytic cells (monocytes and macrophages) (Bourbia et al., 2013). 
Kermanshahi et al. reported that resin composite that is bonded to dentin can be degraded 
when it is exposed to salivary esterase enzymes (Kermanshahi et al., 2010). They 
observed an increased depth of bacteria penetration between dentin and resin composite 
in the specimens that were exposed to esterases for 90 days compared to those that were 
not exposed. The results of this study suggest that biodegradation of the hybrid layer 
increases bacterial microleakage (Kermanshahi et al., 2010). 
The degradation products of resin composite and adhesive resin include 
methacrylic acid (MA), triethylene glycol (TEG), and bishydroxy-propoxy-phenyl-
propane (BisHPPP) (Finer and Santerre, 2003; Khalichi et al., 2009; Shokati et al., 2010; 
Van Landuyt et al., 2011). These products induce human cells (gingival/pulp fibroblasts) 
to release hydrolytic enzymes and cytokines/growth factors resulting in the increased 
degradation of these materials (Gregson et al., 2008; Gregson et al., 2009).  
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These degradation products (i.e., MA, TEG) also regulate the growth and gene 
expression of oral bacteria. Khalichi et al. evaluated the effects of triethylene glycol 
(TEG) and methacrylic acid (MA) on the growth of Streptococcus mutans (S. mutans, 
NG8 and JH1005) and Streptococcus salivarius (S. salivarius, AT2) at pH 5.5 and 7.0. 
Results of their study revealed that both TEG and MA affected the growth of S. mutans 
and S. salivarius in a concentration and pH dependent manner (Khalichi et al., 2004). In 
addition, a study conducted by Hansel et al. showed that the eluates of TEGDMA and 
ethylene glycol dimethacrylate (EGDMA) increased the proliferation of Lactobacillus 
acidophilus and Streptococcus sobrinus (S. Sobrinus) in vitro (Hansel et al., 1998). 
Furthermore, degradation products of resin composite and adhesive resin (i.e., Bis-HPPP, 
TEG and MA) upregulate the expression of glucosyltransferase B (gtfB) of S. mutans that 
is used for the synthesis of extracellular glucans from sucrose and is involved in biofilm 
formation (Khalichi et al., 2009; Singh et al., 2009).  
As a consequence, this degradation process compromises the resin-dentin 
interface, promotes water absorption and more hydrolytic degradation, increases bacterial 
microleakage (Kermanshahi et al., 2010), and contributes to recurrent caries, 
hypersensitivity, and inflammation (Finer and Santerre, 2004; Gregson et al., 2008). 
Degradation of collagen fibrils by matrix metalloproteinases and other proteases 
Among the enzymes trapped in dentin, the MMPs and cathepsins have recently 
gained much attention due to their possible roles in several physiological and 
pathological processes. Interest has been especially focused on the roles of MMPs in 
secondary caries and the degradation of the demineralized dentin that is infiltrated by an 
adhesive resin at the hybrid layer. 
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Matrix metalloproteinases  
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases 
that are able to cleave multiple components of the extracellular matrix. MMPs play a vital 
role in the remodeling of extracellular matrix in physiological conditions such as 
embryogenesis, organ development, and wound healing. Under normal physiological 
conditions, the activities of MMPs are highly regulated at the level of transcription, 
activation of inactive pro-MMPs, interaction with specific extracellular matrix 
components, and inhibition of activated enzymes by endogenous inhibitors (Visse and 
Nagase, 2003).  A loss of their control may result in pathological conditions such as 
arthritis, cancer, atherosclerosis, aneurysms, fibrosis as well as periodontal disease 
(Nagase et al., 2006; Song et al., 2006; Tallant et al., 2010; Visse and Nagase, 2003). 
Structurally, MMPs consist of a prodomain, a catalytic domain, a hinge region, 
and a hemopexin domain. MMPs are either secreted from the cell or anchored to the cell 
membrane. Currently, 24 different MMPs have been identified in vertebrates, and 23 of 
them are found in humans (Visse and Nagase, 2003). Based on their substrate specificity, 
sequence similarity, and domain organization, MMPs can be classified into 6 main 
groups (Table 1) as follows: Collagenases (MMP-1, MMP-8, MMP-13), Gelatinases 
(MMP-2, MMP-9), Stromelysins (MMP-3, MMP-10, MMP-11), Matrilysins (MMP-7, 
MMP-26), Membrane-types MMPs (MMP-14, MMP-15, MMP-16, MMP-17, MMP-25), 
and other MMPs (MMP-12, MMP-19, MMP-21, MMP-28) (Nagase et al., 2006; 
Sbardella et al., 2012; Song and Windsor, 2005; Song et al., 2006; Tjaderhane et al., 
2013b; Visse and Nagase, 2003). Although MMPs share common domain and structures, 
not all MMPs are able to digest fibrillar collagen Type I, II and III. Only collagenases 
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(MMP-1, MMP-8, MMP-13), gelatinase A (MMP-2), and MT1-MMP (MMP-14) are 
able to degrade fibrillar collagen. However, MMP-2 and MT1-MMP cannot cleave 
fibrillar collagen as efficiently as the true collagenases (MMP-1, MMP-8, MMP-13) 
(Feitosa et al., 2014; Song et al., 2006). The collagenolytic process of MMPs involves a 
three-step process, including binding, unwinding, and cleaving of the collagen. The first 
cleavage step of type I fibrillar collagen occurs at the specific cleavage site between 
Gly/Ile of α1(I) chain and between Gly/Leu bond α2(I), generating ¾ N-terminal and ¼ 
C-terminal fragments (Visse and Nagase, 2003). These fragments are further digested by 
gelatinases and other proteinases (Sbardella et al., 2012). 
MMPs are responsible for degradation of extracellular matrix especially type I 
collagen that is a predominant dentin matrix component. MMPs play a crucial role during 
tooth development and are trapped in the mineralized dentin matrix (Nishitani et al., 
2006). Studies reported that MMP-2 (Heikinheimo and Salo, 1995), MMP-3 (Hall et al., 
1999), MMP-9 (Tjaderhane et al., 1998), MMP-8 (Palosaari et al., 2000), and MMP-20 
(Llano et al., 1997; Palosaari et al., 2002; Sulkala et al., 2002) are expressed in human 
odontoblasts and pulp tissue. So far, MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MT1-
MMP and MMP-20 have been found in dentin (Martin-De Las Heras et al., 2000; 
Mazzoni et al., 2011; Mazzoni et al., 2012; Mazzoni et al., 2015; Tjaderhane et al., 2015; 
van Strijp et al., 2003). MMPs are secreted as zymogens or inactive pro-MMPs. Pro-
MMPs can be activated by proteases, other MMPs, heat, and low pH. The activation of 
MMPs occurs through the process called “cysteine switch” where the bond between a 
sulfhydryl group (–SH) of the amino acid cysteine at the pro-domain and Zn2+ ion of the 
catalytic domain is disrupted (Figure 4) resulting in the active forms of MMPs. 
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During the acid-etching procedure of dentin bonding, phosphoric acid of the etch-
and-rinse adhesives or acidic primer of the self-etch adhesives not only demineralizes, 
but also activates pro-MMPs (Figure 4) (Liu et al., 2011; Zhang and Kern, 2009). Active 
MMPs digest the exposed collagen networks that are not completely infiltrated with resin 
monomers and deteriorate the hybrid layer overtime. 
Mazzoni et al. investigated the MMP-2 and MMP-9 activities in dentin powder 
after treatment with different two-step etch-and-rinse and the one-step self-etch adhesives 
using gelatin zymography and enzyme activity assays (BiotrakTM activity assay system) 
(Mazzoni et al., 2013). Their results showed that active MMP-2 and MMP-9 were 
increased after treatment with etch-and-rinse and self-etch adhesives. The results suggest 
that the acid released from the adhesive can activate endogenous MMP-2 and MMP-9 in 
human dentin. Mazzoni et al. also showed MMP-2 and MMP-9 are active at the hybrid 
layer (Mazzoni et al., 2012). Intense MMP activities were observed especially at the 
bottom of the hybrid layer, while the weaker activities were shown on the top of the 
hybrid layer.  
These studies provided the evidence that acid etching is able to activate pro-
MMPs. MMP activities may cause the loss of integrity of the hybrid layer due to collagen 
fibril degradation, especially at the bottom of the hybrid layer where incomplete resin 
infiltration normally occurs. This leads to dentinal fluid influx into the hybrid layer and 
hydrolytic degradation of both adhesive and collagen in the upper parts of the hybrid 
layer. Eventually, the complete destruction of the hybrid layer may contribute to 
secondary caries or failure of the restoration (Kermanshahi et al., 2010). 
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Cysteine cathepsins 
Lysosomal cysteine proteases belong to the family of papain-like enzymes. 
Eleven cysteine cathepsins (cathepsin B, C, F, H, K, L, O, S, V, X and W) have been 
identified (Dickinson, 2002). Like MMPs, cysteine cathepsins participate in extracellular 
matrix degradation and remodeling including the breakdown of type I, II, III and IV 
collagen, laminin, fribronectin, and proteoglycans. The activities of cysteine cathepsins 
are regulated by endogenous cysteine protease inhibitors. Cathepsins may be activated 
autocatalytically during biosynthesis or by other proteases (Mach et al., 1994; Tjaderhane 
et al., 2013b). Cathepsins B, H, L, and C are expressed in all cells and tissues, whereas 
cathepsins S, V, X, O, K, F, and W are present in specific cell types (Obermajer et al., 
2008). Cysteine cathepsins exist as exopeptidases (i.e., cathepsins B, L, and S) that cleave 
the non-helical telopeptide of collagen molecules. Only cathepsin K is able to cleave at 
multiple sites in the triple helix region of the collagen chain generating different 
fragments of collagen molecules (Garnero et al., 1998). Most of cysteine cathepsins work 
under acidic environments. However, some cysteine cathepsins can function at a pH close 
to neutral (i.e., cathepsin K). Cathepsin K has collagenolytic activity on type I collagen at 
pH 5.0–6.5 or gelatinolytic activity at pH 4.0–7.0 (Song et al., 2006). 
Several cysteine cathepsin genes (i.e., cathepsin A, B, C, D, E, F, H, L, O, K and 
Z) have been shown to express in mature human odontoblasts and dental pulp tissues 
(Tersariol et al., 2010). Active cysteine cathepsins were also found in both carious 
(Nascimento et al., 2011; Vidal et al., 2014) and intact (Tersariol et al., 2010) dentin. 
Moreover, cathepsin B was detected in dentinal tubules. These findings indicate that 
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cysteine cathepsins may play an important role during dentinal caries development and 
degradation of the hybrid layer. 
Strategies to prevent the degradation of the hybrid layer 
In recent years, several approaches have been proposed to prolong the durability 
of the hybrid layer and overall clinical success of resin composite restorations. These 
strategies include the use of (1) MMP inhibitors, (2) collagen crosslinking agents, (3) 
ethanol wet bonding with hydrophobic resins, and (4) biomimetic remineralization (Liu et 
al., 2011; Tjaderhane et al., 2013a). One strategy that has been widely investigated is to 
hinder the collagenolytic activity of MMPs using protease inhibitors. These inhibitors 
include galardin (Breschi et al., 2010), chlorhexidine (Montagner et al., 2014; Santiago et 
al., 2013; Talungchit et al., 2014), carbodiimide (Mazzoni et al., 2014), epigallocatechin 
gallate (ECGC) (Khamverdi et al., 2015; Santiago et al., 2013), and doxycycline (Feitosa 
et al., 2014).  
Breschi et al. investigated the effect of galardin (GM6001, a synthetic MMP 
inhibitor) on MMP activities. Galardin has a collagen-like backbone and contains a 
hydroxamate structure (R–CO–NH–OH, where R is an organic residue) (Breschi et al., 
2010). The collagen-like backbone facilitates the binding of galardin to MMP, and 
hydroxamate inhibits MMP activity through chelation of Zn2+ at the MMP active site on 
the catalytic domain (Breschi et al., 2010). Galardin was found to have no negative effect 
on immediate microtensile bond strength (Breschi et al., 2010). After 1 year of aging in 
artificial saliva, microtensile bond strength was significantly decreased in the control 
compared to the galardin-treated group (p<0.05) (Breschi et al., 2010). Investigation of 
interfacial nanoleakage revealed reduced silver deposits in galardin-treated specimens 
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compared to the control (p<0.05) (Breschi et al., 2010). These results suggest that acid 
demineralization is able to activate trapped MMPs and the use of MMP inhibitors could 
provide some resistant to enzymatic degradation of the hybrid layer.  
Santiago et al. evaluated the effects of dentin pretreatment with EGCG on the 
preservation of the resin-dentin bond of etch-and-rinse adhesives (Santiago et al., 2013). 
After 6 months of storage, a significant decrease in bond strength was observed in the 
control group. Dentin pretreatment with EGCG (0.02%, 0.1%, or 0.5%, w/v), as well as 
with 2% chlorhexidine (positive control), preserved the resin-dentin bond after 6 months 
of storage (Santiago et al., 2013).  
Quaternary ammonium compounds such as benzakaonium chloride (BAC) and 
polymerizable quaternary ammonium methacrylates (QAMs) are able to inhibit MMP 
activities. 12-methacryloyloxydodecylpyridinium bromide (MDPB) has been 
incorporated into self-etch primers. Like chlorhexidine, MDPB has antibacterial and anti-
MMP properties as they can chelate Zn2+ of MMPs. A study was conducted to investigate 
the effects of QAMs on MMP activities by incubating demineralized dentin beams with 
or without QAMs, and the loss of dry mass was determined after 30 days. The results 
showed a significant reduction in the loss of dry mass in the dentin beams incubated with 
QAMs (0.2–6.0% loss of dry mass) compared to the control (no QAMs, 29% loss of dry 
mass) (Tezvergil-Mutluay et al., 2011). The unique advantage of QAMs over other MMP 
inhibitors is that they can polymerize with resin monomers (Imazato et al., 2003) and will 
not leach out of the resin-dentin bond interface. 
Chlorhexidine is one of the most commonly investigated MMP inhibitors that 
have been used to prevent the degradation of the hybrid layer. The results from an in vitro 
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study showed that the use of 2% or 0.2% chlorhexidine prevented the loss of bonding 
strength to dentin after aging (Montagner et al., 2014).  Carrilho et al. treated dentin with 
2% chlorhexidine after 37% phosphoric acid etching and showed a significantly higher 
microtensile bonding strength after 14 months compared to no treatment (Carrilho et al., 
2007). Transmission electron microscopy (TEM) also revealed the progressive loss of 
hybrid layer integrity in the control group (Carrilho et al., 2007). These findings suggest 
that using MMP inhibitors can prevent hybrid layer degradation. However, the inhibitory 
effects of chlorhexidine on dentin bond durability were not observed for the longer period 
of aging (i.e., >18 months) (Dutra-Correa et al., 2013; Montagner et al., 2014; Sartori et 
al., 2013). Pallan et al. evaluated the mechanical properties of methacrylate-based resin 
incorporated with chlorhexidine (0.2–2.0%) (Pallan et al., 2012) and found that 
chlorhexidine had no negative impact on water sorption, but 2% chlorhexidine 
incorporation was found to decrease the degree of conversion. The flexural strength and 
modulus of elasticity were slightly increased compared to the control (no chlorhexidine) 
(Pallan et al., 2012). 
A clinical study conducted in non-carious Class V lesions over 36 months 
revealed no improvement in the durability of adhesive restorations when chlorhexidine 
was used prior to an application of the adhesive (Sartori et al., 2013). The long-term 
clinical performance of 70 non-carious cervical lesions with and without the application 
of 2% chlorhexidine to demineralize dentin using split mouth design was also 
investigated. The restoration of the control group started debonding after 6 months of 
clinical function, while none of the restorations in the chlorhexidine treated group 
debonded until 12 months (Sartori et al., 2013). This observation suggested that 
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chlorhexidine stabilized the hybrid layer for up to 12 months. Therefore, a sustained 
release of MMP inhibitor could be an alternative option to provide a long-term and more 
stable resin-dentin bonding.  
Doxycycline 
Tetracycline is a group of broad-spectrum antibiotics that are used for treatment 
of several infectious diseases. There are several derivatives of tetracycline including 
minocycline, oxytetracycline, methacycline, and doxycycline (Kogawa and Salgado, 
2012). Doxycycline (Figure 5) is a semi-synthetic derivative of tetracycline that was 
developed in the early 1960s and was first commercially available in 1967 (Tan et al., 
2011). Doxycycline has activity against a broad range of bacteria including gram-positive 
and gram-negative and some protozoa (i.e., malaria). Doxycycline is also used as a 
prophylactic antibiotic (i.e., malaria), for treatments of sexually transmitted diseases and 
respiratory tract infections (Holmes and Charles, 2009). Three forms of doxycycline are 
commercially available: doxycycline hyclate, monohydrate, and hydrochloride (Kogawa 
and Salgado, 2012). The antibacterial properties of doxycycline occur through the 
inhibition of bacterial protein synthesis by binding to the 30S subunit of ribosome. This 
results in limited access to the t-RNA acceptor site in the mRNA-ribosome complex. 
In addition to its antimicrobial properties, doxycycline has been found to inhibit 
MMPs at a sub-antimicrobial dose in the treatment of periodontal disease (Metzger et al., 
2008). Doxycycline is the only host-modulating drug that has been approved by the Food 
and Drug Administration (FDA) and other national regulatory agencies in Europe and 
Canada as an adjunctive treatment for chronic periodontitis.  
  23 
Since subantimicrobial dose of doxycycline (SDD) has no selective pressure on 
bacteria, no resistant strains would emerge (Greenstein, 1995; Pallasch, 2003). A 
commercially available subantimicrobial dose of doxycycline is Periostat® that is 
prescribed as 20 mg 2×/day (Sgolastra et al., 2011) compared to antibiotic-dose: 100 mg 
1×/day of doxycycline (2×/day for the first day) (Prakasam et al., 2012). SDD is used to 
suppress host-derived MMPs in the periodontal lesion by inhibiting the pathologic 
degradation of collagens in periodontal tissues and to prevent complications of regularly 
administered doses of tetracycline [i.e., gastrointestinal disturbance, increased 
photosensitivity and drug resistance] (Gu et al., 2012). Doxycycline is also used as a 
locally delivered antibiotic such as AtridoxTM (10% doxycycline hyclate, Atrix 
Laboratories, Fort Collins, CO). The inhibitory effect of doxycycline occurs through its 
binding to the Zn2+ located in the catalytic domain of MMPs.  
Aluminosilicate clay nanotubes  
Aluminosilicate clay nanotubes (Halloysite or Halloysite nanotubes, HNT) are 
naturally occurring clay that is formed by rolled kaolin (Lvov et al., 2014). Halloysite is a 
two-layered alumosilicate mineral with a 1:1 ratio of Al:Si and a stoichiometry of 
Al2Si2O5(OH)4.nH2O (Yah et al., 2012b). There are two forms of HNT: the anhydrous 
form (Al2Si2O5(OH)4) with an interlayer of 7 angstroms, and the hydrated form 
(Al2Si2O5(OH)42H2O) with expanded interlayer spacing of 10 angstroms as a 
consequence of water occupied in the interlamellar space (Yah et al., 2012b). The inner 
surface of HNT has chemical properties similar to those of Al2O3 as it is formed by the 
octahedral sheet of Al–OH, while the outer surface has the chemical properties identical 
to those of SiO2 resulting from siloxane groups (Si–O–Si) (Yah et al., 2012a). This 
  24 
difference in chemical composition results in a negatively charged outer surface and a 
positively charged inner lumen. HNT has an outer diameter of approximately 50–70 nm, 
an inner diameter of approximately 10–15 nm, and a length between 500 and 1500 nm 
(Figure 6) (Wei et al., 2014).  
HNT provides several advantages including having abundant hydroxyl groups, 
biocompatibility, hydrophilicity, high mechanical strength, very large surface areas, ease 
in purification and processing, being available in large quantities and much more cost-
effective than many other nano-scaled fillers such as carbon nanotubes/nanofibers 
(Bottino et al., 2013; Chen et al., 2012; Li et al., 2014; Luo et al., 2013; Qi et al., 2012). 
As a result, HNT has been used for a large number of applications such as controlled 
release of protective agents (Ariga et al., 2011; Lvov et al., 2008; Veerabadran et al., 
2009; Vergaro et al., 2010), biomimetic reaction vessels (Shchukin et al., 2005), 
adsorption agents, corrosion prevention agents (Shchukin and Möhwald, 2007), additives 
for improving thermal stability,  and nucleating agents for crystallization of polymers 
(Luo et al., 2013).  
The Young’s modulus of HNT calculated using the geometric optimization 
protocol has been reported to be approximately 230–340 GPa (Guimaraes et al., 2010). 
Because of the high mechanical properties, biocompatibility and hydrophilicity, HNT has 
been used as reinforcing material in engineered composites (Qi et al., 2010; Qi et al., 
2012; Qi et al., 2013; Ye et al., 2007) and polymers in dentistry (dental resin composite, 
adhesive resin) (Bottino et al., 2013; Chen et al., 2012). 
A study conducted by Chen et al. (Chen et al., 2012) on resin composite 
impregnated with different amounts of HNT found that incorporation of 1% and 2.5% of 
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silanized HNT significantly improved the flexural strength and elastic modulus of Bis-
GMA/TEGDMA resin composite. However, a high mass fraction of HNT (5%) did not 
increase these properties (Chen et al., 2012). The results suggested that the incorporation 
of HNT into Bis-GMA/TEGDMA resin composite could result in two opposite effects: 
the reinforcing effect due to highly separated and uniformly distributed HNT and the 
weakening effect due to agglomeration of HNT particles.  
Similarly, it has been shown that the incorporation of nanofillers with different 
properties (chemical compositions, sizes, shapes and morphological characteristics) into 
adhesive resin would enhance the resin-dentin bond strength and the mechanical 
properties of the adhesive layer (Conde et al., 2009; Kim et al., 2005; Lohbauer et al., 
2010; Miyazaki et al., 1995; Sadat-Shojai et al., 2010; Solhi et al., 2012). The nanoscale 
particle size and the increased surface area associated with HNT may reinforce the 
polymer matrix via crack deflection and localized plastic deformation around the fillers 
(Bottino et al., 2013). Furthermore, it has been suggested that nanofillers can infiltrate 
into the dentinal tubules, decreasing polymerization shrinkage, stiffening the adhesive 
layer, and ultimately strengthening the adhesive layer (Lohbauer et al., 2010; Sadat-
Shojai et al., 2010).  
The effects of HNT incorporated into the adhesive resin on degree of conversion, 
Knoop microhardness, and dentin shear bond strength have been reported (Bottino et al., 
2013). HNT was incorporated into a commercially available three-step etch-and-rinse 
adhesive (Adper Scotchbond Multi-Purpose, SBMP) at five distinct concentrations (5%, 
10%, 15%, 20% and 30%, w/v). The results revealed that incorporation of HNT at 30% 
(w/v) into the adhesive resin showed the highest dentin shear bond strength and Knoop 
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microhardness number, and was significantly higher than the control (unfilled adhesive). 
For the degree of conversion, incorporation of HNT up to 20% (w/v) had no negative 
effect. However, at 30% (w/v), DC was significantly decreased compared to the control. 
The results of this study suggested that the incorporation (5–30%, w/v) of HNT into 
adhesive resin had no negative effect on dentin shear bond strength and Knoop 
microhardness. However, due to a significant reduction in DC at 30% HNT-loading 
compared to the unfilled adhesive, HNT can be incorporated up to 20% (w/v) without 
compromising the physicochemical properties of adhesive resin. 
Specific Aims 
The ultimate goal of this study was to evaluate doxycycline (DOX), an FDA 
approved MMP inhibitor, for its effects on preventing hybrid layer degradation through 
the modification of dental adhesive with aluminosilicate clay nanotubes (HNT). 
Doxycycline was encapsulated into HNT, and DOX-encapsulated HNTs were 
incorporated into dental adhesive (Adper Scotchbond multi-purpose [SBMP], 3M ESPE). 
Physico-chemical and mechanical characteristics of the dental adhesive were first 
investigated. Then, doxycycline released from the dental adhesive was evaluated for its 
inhibition of MMP activity. The immediate microtensile bond strength of the resin-dentin 
bonding was evaluated (24 h bond strength).  
The central hypothesis of this study was that doxycycline would be released 
overtime from the modified adhesives (DOX-loaded dental adhesive) at subantimicrobial 
levels, and the released doxycycline would inhibit MMP activity. These studies were 
accomplished under the following specific aims. 
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Specific aim 1: To investigate the anti-MMP activity and the microtensile bond strength 
of the modified adhesive (dental adhesive loaded with 10% DOX-encapsulated HNT). 
This specific aim was mainly a proof of concept that the release of doxycycline 
from DOX-encapsulated HNT modified adhesive was at subantimicrobial levels and that 
the released doxycycline inhibited MMP activity without compromising the resin-dentin 
microtensile bond strength.  
Specific aim 1A: To fabricate the modified adhesive (dental adhesive loaded with 10% 
DOX-encapsulated HNT) and to evaluate the antimicrobial activity of the doxycycline 
released from 10% DOX-encapsulated HNT modified adhesive. 
Hypothesis: Doxycycline would be released from the modified adhesive at 
subantimicrobial levels and inhibit MMP activity. 
Specific aim 1B: To evaluate the microtensile bond strength of the resin-dentin bonding 
after 24 h in artificial saliva. 
Hypothesis: No significant differences in resin-dentin microtensile bond strength after 24 
h in artificial saliva would be found between the modified adhesive groups and the 
control (SBMP).  
Specific aim 2: To investigate the release of doxycycline from modified adhesives 
(dental adhesives loaded with 10%, 20% and 30% of DOX-encapsulated HNT) and the 
effect of the released doxycycline on MMP activity. 
This specific aim included the experiments that were conducted in specific aim 1 
with increasing concentrations of doxycycline (10%, 20% and 30% doxycycline). The 
encapsulation efficiency and the amount of released doxycycline were also determined. 
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Specific aim 2A: To encapsulate doxycycline into aluminosilicate clay nanotubes at 
three distinct concentrations (10% DOX, 20% DOX and 30% DOX, w/v) and to fabricate 
the modified adhesives. 
Hypotheses: The incorporation of DOX-encapsulated HNT into dental adhesives would 
not significantly increase the degree of conversion and Knoop microhardness.  
Specific aim 2B: To determine the amount of doxycycline released from modified 
adhesives and the effect of released doxycycline on MMP activity. 
Hypotheses: Doxycycline would be released from the dental adhesive loaded with DOX-
encapsulated HNT at subantimicrobial levels and inhibit MMP activity. 
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MATERIALS AND METHODS 
Specific aim 1 
Encapsulation of doxycycline into aluminosilicate clay nanotubes 
Doxycycline hyclate (Sigma Aldrich, St. Louis, MO, USA) was dissolved at 10% 
(w/v) in phosphate buffered saline (PBS; pH 7.2, Fisher Scientific, Pittsburgh, PA, USA) 
at 50°C for 2 h under stirring conditions (Fisher Thermix, model 310T, Fisher Scientific).  
The encapsulation process was modified from a previously reported procedure (Qi 
et al., 2010). Aluminosilicate clay nanotubes (HNT; Dragonite 1415JM, Applied 
Minerals Inc., New York, NY, USA) were sieved (<45 µm sieve) prior to use. HNT (1 g) 
was mixed in 10 mL of doxycycline, and sonicated for 2 h to enhance dispersion. 
Vacuum (25 in Hg) was applied and maintained for 1 h to remove any air between and 
within the HNT. The solution was then stirred for 1 h and vacuum was reapplied. Finally, 
the solution was dried in an incubator at 37°C for 5 days. The dried powder was ground 
and sieved (<45 µm) prior to use.   
Fabrication of DOX-encapsulated nanotube modified adhesives 
Three groups were investigated as follows:  
1. Control: unmodified adhesive (SBMP without HNT and doxycycline),  
2. HNT: SBMP + HNT  
3. 10% DOX: SBMP + 10% DOX-encapsulated HNT.  
The modified adhesives were fabricated by incorporating either HNT or DOX-
encapsulated HNT into a commercially available three-step etch-and-rinse adhesive 
bonding system (Adper Scotchbond Multi-Purpose [SBMP]; 3M ESPE, St. Paul, MN, 
USA) at 15% (w/v). It was previously reported that HNT could be incorporated up to 
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20% (w/v) without jeopardizing the physico-chemical and bonding properties of the 
adhesive (Bottino et al., 2013). However, the modified adhesives were fabricated with 
15% (w/v) because 20% HNT (w/v) resulted in high viscosity of the modified adhesive.  
The DOX-encapsulated HNT powder was incorporated (75 mg of DOX-
encapsulated nanotubes per 500 µL of adhesive) into the dental adhesive (SBMP) by 
mixing with a stirrer and a conical micropestle (Roti-Speed, Roth, Karlsruhe, Germany) 
followed by sonication (Ultrasonic cleaning L&R 2014, Mfg Co., Kearney, NJ, USA) for 
1 h to further enhance HNT dispersion. The modified adhesives were fabricated with 
light-proof (amber) microcentrifuge tubes because of photosensitivity of doxycycline. All 
specimens were fabricated in a constant temperature room (23°C) with a filtered lighting 
system to minimize unintentional polymerization. 
Degree of conversion 
Degree of conversion (DC) was used to determine whether adhesive 
polymerization was affected by the incorporation of doxycycline. Disc-shaped specimens 
(7 × 0.24 mm, n = 5) were fabricated and light cured for 10 sec (manufacturer’s 
recommendation), 20 sec, or 40 sec. A light-emitting diode curing system (DEMI LED, 
Kerr, Orange, CA, USA) with an approximate output irradiance of 1,300 mW/cm2 was 
used, and the output was periodically monitored using a Cure Rite Visible Light Meter 
(Dentsply Caulk, Milford, DE, USA). The amounts of energy applied onto specimen 
disks during light curing of 10 sec, 20 sec and 40 sec were measured with a MARC Resin 
Calibrator (BlueLight analytics Inc, Halifax, NS, Canada) and were 10.92 J/cm2, 22.49 
J/cm2 and 46.18 J/cm2, respectively.  
  31 
Prepared specimens were stored at room temperature for 24 h in a dark and dry 
condition. Degree of conversion was evaluated with Fourier transform infrared 
spectroscopy (FTIR; Jasco 4100, Jasco Corp., Tokyo, Japan) in attenuated total reflection 
mode. The area under 2 absorbance bands at 1,637 cm−1 (methacrylate group C=C) and 
1,715 cm−1 (ester group C=O) was used in the following equation to calculate the degree 
of conversion: 
DC (%) = (1− Cured (area under 1637 cm!1 area under 1715 cm!1 )
Uncured (area under 1637 cm!1 area under 1715 cm!1))×100 
Antibacterial properties 
In order to prove successful encapsulation of doxycycline in modified adhesives 
and to further support our hypothesis that the DOX-encapsulated HNT modified 
adhesives would release doxycycline at subantimicrobial levels, antimicrobial activity 
was assessed by agar diffusion testing. 
Agar diffusion tests of the modified adhesive disks and the doxycycline 
containing eluates (PBS eluates) against Streptococcus mutans (S. mutans, UA159) were 
performed. 
Antibacterial properties of the modified adhesive disks 
Disk-shaped adhesive specimens (6.2 × 2 mm, n = 4 per group) were fabricated 
and light cured for 10 sec. Specimens were kept at room temperature for 24 h, and 
disinfected by ultraviolet light exposure (30 min/side). S. mutans was cultured aerobically 
in tryptic soy broth (Difco Laboratories, Detroit, MI, USA) for 24 h in 5% CO2 at 37°C. 
Then, 100 µL of the bacterial suspension was swabbed onto blood agar plates to create a 
lawn of bacteria (Palasuk et al., 2014). The disinfected specimens were directly placed on 
blood agar plates (bioMerieus Inc., Durham, NC, USA) containing a freshly prepared 
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lawn of bacteria. The blood agar plates were incubated in 5% CO2 at 37°C. After 72 h of 
incubation, the diameters (in mm) of the clear zones of growth inhibition were 
determined. Chlorhexidine (0.12%) and sterile PBS were used as positive and negative 
control, respectively. 
Antibacterial properties of the doxycycline containing eluates 
Disk-shaped specimens (5 mm × 2 mm, n = 4) were fabricated as previously 
described and individually incubated at 37°C in 10 mL of PBS (pH 7.2). One mL of 
aliquot containing doxycycline (leached from specimen disks) was collected at day 1, 7 
and 14. An equal amount of sterile PBS was added to replace the removed volume. 
Aliquots were stored at −20°C until tested.  
S. mutans was cultured and plated on blood agar plates as previously described. 
Each agar plate was divided into zones and a 10 µL aliquot from days 1, 7, and 14 were 
pipetted into the center of each zone (Palasuk et al., 2014). The blood agar plates were 
incubated in 5% CO2 at 37°C. After 72 h of incubation, the diameters (in mm) of the 
clear zones of growth inhibition were determined. Chlorhexidine (0.12%) and sterile PBS 
were used as positive and negative control, respectively. 
MMP mediated casein cleavage assays 
Disk-shaped specimens (5 mm × 2 mm, n = 4) were fabricated, placed into 12-
well plates and incubated in 2 mL of 50 mM Tris with 0.2 M NaCl, 10 mM CaCl2, and 1 
µM ZnCl2 (pH 7.4). On days 1, 7, and 14, aliquots (500 µL) from the modified adhesives 
(doxycycline containing eluates) were collected. An equal volume of the buffer was 
added to keep the volume constant. Aliquots were stored at −20°C until tested. MMP-1 
purified from human gingival fibroblast-conditioned media by anticollagenase affinity 
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chromatography (Windsor et al., 1994; Windsor et al., 1997) was activated with 4-
aminophenylmercuric acetate (APMA, Sigma-Aldrich, St. Louis, MO, USA). The 
activation was performed by incubation of 10 mM APMA (10×) with purified MMP-1 
(1:9 ratio by volume) at 37°C for 90 min.  
APMA activated MMP-1 (100 µL) was incubated with β-casein (100 µL, 5 
mg/mL) at 37°C (Windsor et al., 1994; Windsor et al., 1997) with or without the 
doxycycline containing eluates (200 µL, n = 4) in a total volume of 400 µL. Samples (65 
µL) were periodically (0–120 min) removed, and the reaction was terminated by addition 
of 1,10-phenanthroline (10 µL, 200 mM) to a final concentration of 10 mM. Samples 
were resolved in 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE), stained with Coomassie blue, and analyzed using ImageJ software (NIH, 
Bethesda, MD). The positive and negative controls were 0.1% doxycycline and Tris 
buffer, respectively. 
Cytocompatibility  
Cytotoxicity of modified adhesives with and without doxycycline, as well as 
control (SBMP), was evaluated on human dental pulp stem cells (hDPSCs). 
Adhesive disks (5 × 2 mm; n = 4) were fabricated as previously described. The 
doxycycline containing eluates were prepared following the guidelines of the 
International Standards Organization (1993). In brief, a 1:2 ratio of the elution solution 
(low-glucose [1 g/L] Dulbecco's Modified Eagle's Medium [DMEM], Corning Cellgro, 
Manassas, VA, USA) and the adhesive disk volume (i.e., 1 mL of DMEM to 2 mm3) was 
used (Zhang et al., 2013a; Zhang et al., 2013b). The adhesive disks were disinfected by 
ultraviolet light exposure (30 min/side) and then individually immersed in 19.64 mL of 
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DMEM supplemented with 10% fetal bovine serum (FBS, Hyclone, Logan, UT, USA) 
and 1% penicillin-streptomycin (Sigma), placed in a shaker, and mixed at 37°C at 50 rpm 
for 24 h. 
To mimic clinical conditions, the eluates were serially diluted as follows: 32-fold 
(1 mL of original eluate + 31 mL of DMEM), 64-fold, and 128-fold (Zhang et al., 2013a; 
Zhang et al., 2013b). The rationale was that the average daily salivary flow is of 
proximately 1000–1500 mL (Humphrey and Williamson, 2001). These dilutions 
corresponded to a total solution of 483 mL, 966 mL, and 1933 mL, respectively. This 
corresponded to approximately ½, 1, and 1.5 fold of the normal saliva amount per day, 
taking into account patients with reduced or increased saliva production. 
Human dental pulp cells (hDPCs) were cultured in low-glucose DMEM (Corning 
Cellgro, Manassas, VA, USA) supplemented with 10% FBS (Hyclone, Logan, UT, USA) 
and 1% penicillin-streptomycin (Sigma). Cells at passages 3–8 were used in these 
experiments. Human DPSCs were seeded at the density of 3,000 cells per well in 96-well 
plates in 100 µL of culture medium (Feitosa et al., 2014). After 24 h of incubation at 
37°C and 5% CO2, the culture medium was removed and replaced with 100 µL of 
previously prepared DMEM eluates.  
After 48 h, 15 µL of dye solution (CellTiter 96 Non-Radioactive Cell 
Proliferation Assay/MTT; Promega, Madison, WI, USA) was added to each well. After 4 
h of incubation, 100 µL of Solubilization/Stop Mix was added into each sample. The 
optical density was measured at 570 nm after an overnight incubation, and the reading 
was subtracted by the background optical density measured at 680 nm. Blank wells were 
prepared using culture medium without cells. Positive (100% survival, untreated cells) 
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and negative (total cell death) controls were DMEM with cells but without the eluates 
(100% survival) and a 0.3% phenol solution (v/v), respectively.  
The absorbance values of the treated cells were subtracted by the absorbance 
values of the blank, and the following equation was used to calculate cell proliferation: 
Cell proliferation %  = Absorbance value of treated cells
Absorbance value of untreated cells
×100 
Dentin bonding 
Thirty-six extracted non-carious human third molars (n = 12) stored in 0.1% 
thymol solution were used within 6 months of extraction with an Institutional Review 
Board approval (NS1004-03, Indiana University). Teeth were sectioned to expose mid-
coronal dentin using a low-speed diamond disk (Buehler Ltd., Lake Bluff, IL, USA) and 
examined under a stereomicroscope (40×) for the absence of enamel. A midcoronal 
dentin surface was polished with SiC papers (240–600 grit) to create a flat surface and to 
standardize the smear layer. Teeth were then randomly assigned into 3 groups according 
to the types of dental adhesive used: unmodified adhesive (control, SBMP), HNT (SBMP 
+ HNT), 10% DOX (SBMP + 10% DOX-encapsulated HNT). The bonding procedure 
was performed as recommended by the manufacturer’s instruction. Briefly, dentin 
surfaces were etched with 37% phosphoric acid for 15 sec, rinsed with deionized water 
for 15 sec, air dried for 5 sec, primed, bonded, and polymerized (DEMI LED, Kerr, 
Orange, CA, USA). Teeth were incrementally restored with resin composite (~1–2 mm 
thick/increment; Z100, 3M ESPE). All specimen blocks were stored at 37°C in deionized 
water for 24 h. 
Bonded specimens were cut perpendicular to the resin-dentin interface using a 
slow-speed water-cooled saw equipped with a diamond-impregnated disk (Isomet, 
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Buehler, Lake Bluff, IL, USA) to produce 0.8 × 0.8 mm beams. The beams were kept in 
artificial saliva at 37°C for 24 h. 
Microtensile bond strength testing 
The beams were placed in a notched Geraldeli jig (ODEME Biotechnology, 
Joacaba, SC, Brazil) for microtensile testing using cyanoacrylate resin (Loctite Superglue 
Control Gel, Henkel Corporation, Avon, OH, USA). All beams were loaded with tension 
in a universal testing machine (MTS Sintech Renew 1123, Eden Prairie, MN, USA) until 
fracture at a crosshead speed of 1 mm/min. 
Failure mode analysis 
Fracture surfaces (121 beams, 80% recovery) were examined under a 
stereomicroscope (40×). The types of failure were classified as cohesive failure in dentin, 
cohesive failure in resin composite, adhesive failure (within the adhesive layer), or mixed 
failure (combination of adhesive and cohesive failures). 
Scanning electron microcopy (SEM) 
Randomly selected fractured specimens were sputter coated with gold (Denton 
Vacuum Desk II cold sputter, Moorestown, NJ, USA) and imaged with a scanning 
electron microscope (SEM; JSM-5310LV, JEOL, Tokyo, Japan).  
Statistical analysis 
Data were analyzed using one-way ANOVA, except the microtensile bond 
strength data in which a mixed-model ANOVA was used. Tukey’s test was used for post 
hoc comparisons. The level of significance was set at 0.05. 
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Specific aim 2 
Encapsulation of doxycycline into aluminosilicate clay nanotubes  
Doxycycline hyclate (Sigma Aldrich, St. Louis, MO, USA) was dissolved in 50 
mM HEPES buffer (pH = 7.2) using a vortex mixer at three distinct concentrations (w/v) 
as follows: 
1. 10% DOX: 0.5 g of doxycycline powder in 5 mL of 50 mM HEPES, 
2. 20% DOX: 1.0 g of doxycycline powder in 5 mL of 50 mM HEPES  
3. 30% DOX: 1.5 g of doxycycline powder in 5 mL of 50 mM HEPES. 
During the encapsulation process, the weight of 15-mL polypropylene tubes, 
doxycycline, and HNT used for the encapsulation was recorded to determine 
encapsulated doxycycline and unencapsulated doxycycline.  
Aluminosilicate clay nanotubes (HNT, <45 µm sieved) were mixed with 
doxycycline solution at 25% (w/v, 1.25 g in 5 mL of doxycycline solution) and sonicated 
for 2 h. Vacuum (25 in Hg) was applied and maintained for 1 h. The solution was mixed 
for 1 h using end-to-end mixer and vacuum was reapplied for another 1 h. Finally, the 
solution (DOX+HNT) was centrifuged at 3000 rpm for 10 min. The supernatants were 
collected and stored at −20°C for high-pressure liquid chromatography (HPLC) analysis. 
The pellets (DOX-encapsulated HNT) were dried in an incubator at 37°C for 7 days. The 
dried pellets were weighed, recorded, ground, and sieved (<45 µm) prior to use.  
Encapsulation efficiency and drug loading 
Incorporation of doxycycline into HNT was characterized by two techniques 
(n=5).  
1. By dry weight  
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Since the amount of doxycycline that was added in each group (i.e., 0.5 g in 10% 
DOX, 1.0 g in 20% DOX and 1.5 g in 30% DOX), the dry weight of the pellets (DOX + 
HNT) and the amount of HNT added were known, the amounts of encapsulated 
doxycycline and unencapsulated doxycycline were calculated as follows: 
Encapsulated DOX (mg) = DOX added (mg) + HNT added (mg)− pellet (mg) 
Unencapsulated DOX (mg) = DOX added (mg)− encapsulated DOX (mg) 
2. By High-pressure liquid chromatography (HPLC)  
HPLC was used to determine doxycycline concentration in supernatant (SUP) 
after drug encapsulation. Since the volume of supernatant and the amount of doxycycline 
added in each group were known, the amounts of unencapsulated doxycycline 
(doxycycline in the supernatant) and encapsulated doxycycline were calculated as 
follows:  
Unencapsulated DOX (mg) = conc. of DOX in SUP (mg/mL) × vol. of SUP (mL) 
Encapsulated DOX (mg) = Amount of DOX added (mg)− unencapsulated DOX (mg) 
High-pressure liquid chromatography (HPLC)   
High-performance liquid chromatography (HPLC) equipped with a UV-Vis 
detector was used to determine the doxycycline content using maximal absorption peaks 
at 273 nm. HPLC analysis was performed on an Agilent 1100 system (Palo Alto, CA) 
using an Eclipse XDB-C18 chromatography column (3.5 µm, 150 × 4.6 mm) with a 10 
µL injection volume. A binary mobile phase consisting of solvent systems A and B was 
used in an isocratic elution with 80:20 A:B. Mobile phase A was 50 mM KHPO4 in dH20 
and mobile phase B was 100% acetonitrile. The HPLC flow rate was 1.0 mL/min and the 
total run time was 10 min. The retention time of doxycycline was 4.85 min. The 
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concentration of doxycycline was calculated from a standard curve of doxycycline (r2 = 
0.99984).  
The percent of encapsulation efficiency and drug loading were calculated using 
the following equations (Patel et al., 2013): 
Encapsulation efficiency % =
Da− Ds
Da
×100  
 
Drug loading % =
Da− Ds
Na
×100  
 
Where  Da = total amount of drug added (g) 
Ds = unencapsulated doxycycline (g) determined by HPLC (the amount of 
drug in supernatant after centrifugation) or by dry weight 
Na = total of amount of HNT (1.25 g) 
Fabrication of DOX-encapsulated nanotube modified adhesives 
Three groups according to the concentrations of doxycycline and two control 
groups were investigated as follows:  
1. Control: unmodified adhesive (SBMP without HNT and doxycycline),  
2. HNT: SBMP + HNT (no doxycycline) 
3. 10% DOX: SBMP + 10% DOX-encapsulated HNT  
4. 20% DOX: SBMP + 20% DOX-encapsulated HNT  
5. 30% DOX: SBMP + 30% DOX-encapsulated HNT 
The modified adhesives were fabricated as previously described. 
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Degree of conversion 
Degree of conversion (n = 5) was used to determine whether polymerization of 
the modified adhesives was affected by the incorporation of doxycycline and was 
evaluated as previously described.  
Knoop microhardness 
Microhardness is an alternative technique to determine the degree of conversion 
because of a strong positive correlation between microhardness and degree of conversion 
(Ferracane, 1985). This study determined the Knoop microhardness of the specimens 
with the same dimension as were used for drug release profiling to ensure that the release 
of doxycycline was not due to underpolymerization. 
Disc-shaped specimens of the adhesive for all of the groups (6.2 × 1.0 mm, n = 5) 
were fabricated and light cured for 20 sec on each side and stored at room temperature for 
24 h in the dark and dry condition. Specimens were embedded in self-cure epoxy resin 
(EpoxiCure®, Buehler, Lake Bluff, IL, USA) and polished with SiC paper (1200 grit) for 
10 sec. Specimens were subjected to a microhardness test (M-400, Leco Corp., St. 
Joseph, Michigan USA) using a Knoop diamond indenter at a 50 gf load and 15 s dwell 
time. Five readings at different locations (at least 1 mm apart) were obtained from each 
specimen. The diagonal lengths were measured immediately after each indentation. The 
values were converted to KHN number (kg/mm2). 
Doxycycline release profile 
 Disc-shaped specimens of the adhesive for all the groups (6.2 × 1.0 mm, n = 6) 
were fabricated as previously described. Specimen disks were individually incubated at 
37°C in 1 mL of phosphate buffer saline (PBS, pH 7.4). To collect doxycycline-
  41 
containing eluates, 150 µL aliquots were collected after 1, 7, 14, 21, and 28 days. An 
equal amount of sterile PBS was added to replace the removed volume. Aliquots were 
stored at −20°C until used. 
Mass spectrometry   
High performance liquid chromatography tandem mass spectrometry (HPLC-MS-
MS, Agilent 6460 Triple Quadrupole LC/MS) was used to determine the concentration of 
doxycycline released from the specimen disks. The analysis was performed with an 
XBridge-C18 chromatography column (3.5 µm, 100 × 2.1 mm) with a 5 µL injection 
volume. The mobile phase consisted of 0.1% formic acid in deionized water (A) and 
0.1% formic acid in acetonitrile (B) under an isocratic condition (A:B, 80:20). A flow 
rate of 0.30 mL/min was used. The mass spectrometer was operated in multireaction 
monitoring (MRM) mode. The transition for doxycycline was mass:charge (m/z) at 445.1 
(MS1) and 428.1 (MS2). The concentration of doxycycline release was calculated from a 
standard curve of doxycycline (r2 = 0.99986). 
Doxycycline in specimen disk  
The amount of doxycycline in one adhesive disk was determined by two 
techniques as follows: 
1. Dissolve modified adhesive disk in dimethyl sulfoxide (DMSO) 
Disc-shaped specimens of the adhesive for all the groups (6.2 × 1.0 mm, n = 3) 
were fabricated as previously described. Specimen disks were individually incubated at 
37°C in 1 mL of DMSO to completely dissolve the adhesive after 48 h. The 
DOX+DMSO solutions were centrifuged at 4000 rpm for 5 minutes, and the supernatants 
that contained doxycycline were collected and stored at −20°C until used for mass 
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spectrometry analysis. This provided the amount of doxycycline that was incorporated 
into each adhesive disk (total doxycycline in the adhesive disk). 
2. Dissolve 7.5 mg of DOX-encapsulated HNT powder in ethanol. 
7.5 mg of DOX-encapsulated HNT powder (n = 5) was individually incubated at 
37°C in 1 mL of ethanol for 48 h. The solutions were centrifuged at 4000 rpm for 5 
minutes, and the supernatants that contained doxycycline were collected and stored at 
−20°C until used for mass spectrometry analysis.  
Doxycycline remained in the adhesive disk after 4 months of incubation 
 After 4 months of incubation at 37°C in PBS, specimen disks were individually 
dissolved in DMSO and processed for mass spectrometry analysis as previously 
described. This provided the amount of doxycycline that remained in each adhesive disk. 
Antibacterial properties 
Agar diffusion tests against Streptococcus mutans (UA159) and Lactobacilli casei 
(ATCC 393) was performed as follows: 
1. Antibacterial properties of the adhesive disks (n = 3) 
2. Antibacterial properties of doxycycline containing eluates (n = 3).  
The same PBS eluates that were used for doxycycline release profiling were also 
used for the agar diffusion tests as previously described. 
Anti-matrix metalloproteinase activity assay  
To evaluate anti-MMP activity of DOX-encapsulated nanotube-modified 
adhesives, doxycycline-containing eluates were collected in Tris buffer. The fluorescein 
isothiocyanate (FITC) labeled type I collagen cleavage assay was used to determine the 
MMP inhibition by the eluates collected in Tris buffer. 
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Doxycycline containing eluates in Tris buffer (Tris eluates) 
Disk-shaped specimens of the adhesive for all the groups (6.2 × 1.0 mm, n = 4) 
were fabricated as previously described. After 24 h, specimen disks were individually 
incubated at 37°C in 1 mL of Tris buffer (50 mM Tris-HCl, 0.2 M NaCl, 5 mM CaCl2, 1 
µM ZnCl2, and 15 mM NaN3, pH 7.4). To collect doxycycline containing eluates, 150 µL 
aliquots were collected after 1, 7, 14, 21, and 28 days. An equal amount of tris buffer was 
added to replace the removed volume. Aliquots were stored at −20°C until tested. 
Labeling type I collagen with fluorescein isothiocyanate  
Rat-tail tendon (RTT) type I collagen was purified and labeled with fluorescein 
isothiocyanate (FITC, sigma-Aldrich) as previously described (Birkedal-Hansen et al., 
2003). RTT was dissolved in 20 mM acetic acid at 4 mg/mL under a stirring condition at 
4°C for 48 h. An equal volume  (5 mL each) of 4 mg/mL of RTT and 20 mM acetic acid 
were mixed. After the addition of Dulbecco’s Modified Eagle’s Medium (DMEM, 10 
mL), the mixture was neutralized with NaOH, immediately transferred into a 10-cm 
diameter dish, and incubated at 37°C overnight to form gels. Gels were washed twice 
with borate buffer (0.05 M NaB4O7.10H2O, pH 9.3 and 0.04 M NaCl). The buffer was 
replaced with 10 mL borate buffer containing FITC (2 mg/mL), and the gels were 
incubated at room temperature for 30 min until the dye diffused into the gels. Then, the 
gels were washed with multiple changes of PBS for several days until the washing 
solution was clear of excess FITC. Gels were washed with deionized water to remove salt 
and re-dissolved in 5 mL 0.2 M acetic acid at 4°C. FITC labeled type I collagen was 
dialyzed using dialysis membrane (Spectra/Por 2 dialysis tubing, 12–14K MWCO) 
against 13 mM HCl. 
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Activation of matrix metalloproteinase-1 
 Human full-length matrix metalloproteinase I (MMP-1, 0.05 mg/mL, Abcam, 
Cambridge, MA, USA) was activated with 4-aminophenylmercuric acetate (APMA, 
Sigma-Aldrich, St. Louis, MO, USA). Briefly, 10 µL of MMP-1 was incubated with 10 
µL of 10 mM APMA (10×, pH 7.4) and 80 µL of buffer (50 mM Tris-HCl, 0.2 M NaCl, 5 
mMCaCl2, 1 µM ZnCl2 and 15 mM NaN3) at 37°C for 90 min (Windsor et al., 1997). The 
activation was confirmed by western blot analysis. 
Western blot analysis 
After 90 min at 37°C, the activated and inactivated MMP-1 was mixed with 
loading buffer and resolved in 10% sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) at 120 V. The proteins were transferred onto nitrocellulose 
membranes (Bio-Rad) using blotting buffer (2 mM Tris-HCl, pH 8.3, 192 mM glycine, 
and 10% methanol) at 100 V for 60 min. The membranes were blocked with 5% (w/v) 
non-fat milk for 1 h in phosphate buffered saline (PBS) containing 0.1% Tween-20 and 
then incubated overnight at 4°C with the primary antibodies. The monoclonal Ab-5 (1 
µg/mL, Clone III12b, Neomarkers, Fremont, CA, USA) for MMP-1 was used. The 
membranes were then incubated with secondary antibodies (HRP conjugated anti-rabbit 
IgG at 1:10,000 ratio, GE Healthcare Life Sciences, Piscataway, NJ, USA) for 1 h at 
room temperature. The immune complexes were detected using the Pierce Fast Western 
Blot Kit and SuperSignal West Pico Substrate (Thermo Scientific, Rockford, IL, USA) 
according to the manufacturer’s protocol.  
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FITC labeled type I collagen cleavage assay 
 Doxycycline containing eluates in Tris buffer (150 µL, n = 4, 50 mM Tris-HCl, 
0.2 M NaCl, 5 mM CaCl2, 1 µM ZnCl2 and 15 mM NaN3, pH 7.4) were incubated with 
APMA activated MMP-1 for 30 min at room temperature. Then, Tris buffer (200 µL) and 
FITC labeled type I collagen (50 µL) were added and the mixture was incubated at 37°C 
for 120 min. The negative and positive controls were Tris buffer and 0.1% doxycycline, 
respectively. Samples (70 µL) were periodically (0–120 min) removed, and the reaction 
was terminated by addition of 1,10-phenanthroline (200 mM, 10 µL) to a final 
concentration of 25 mM. Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) sample buffer was added (1:1). Samples were boiled for 10 min and 
resolved in 8% SDS-PAGE (150 V, 3 h). The fluorescent signals were captured using 
Bio-Rad imaging system (Gel DocTM XR imaging system). The fluorescence intensity at 
0 min and 120 min incubation was analyzed with ImageJ software (National Institutes of 
Health, Bethesda, MD, USA). The percent of FITC labeled RTT of buffer (negative 
control), 0.1% doxycycline (positive control), and DOX eluates was calculated as 
follows: 
Cleaved RTT %  = (1− Fluorescent density at 2 h 
Fluorescent density at 0 h
)×100 
The inhibition bydoxycycline containing eluates was calculated using the 
following equation. 
Inhibition %  = 
Cleaved RTT in buffer (%)− cleaved RTT of DOX eluates (%)
Cleaved RTT in buffer (%)
×100 
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Cytocompatibility 
Adhesive disks (6.2 × 1 mm; n = 4) were fabricated and the doxycycline 
containing eluates were prepared by individually immersing the specimen disks in 15.1 
mL of low glucose (1g/L) DMEM supplemented with 10% FBS (Atlanta Biologicals, 
Lawrenceville, GA, USA), 100 U/mL penicillin (Sigma-Aldrich, St. Louis, MO, USA), 
50 mg/mL gentamicin (Invitrogen Life Technologies, Carlsbad, CA, USA) under shaking 
conditions (50 rpm) at 37°C for 24 h. 
Cytotoxicity of the adhesive eluates was evaluated on human dental pulp stem 
cells (hDPSCs) using water-soluble tetrazolium-1 (WST-1, Roche Diagnostics, 
Indianapolis, IN, USA) according to the manufacturer’s instruction (Zhang et al., 2010) 
and as previously described. 
Transmission electron microscopy (TEM)  
TEM was used to evaluate the interface between resin composite and modified 
adhesive. Disk-shaped specimens (7 × 2 mm) were fabricated using a custom-made 
silicone mold (Exaflex putty, GC America Inc., Alsip, IL, USA). Briefly, resin composite 
was placed into the mold and light cured for 40 sec followed by the application of 
modified adhesive (HNT without doxycycline) and light curing for 20 sec. The adhesive 
without HNT (SBMP) was used as a control. Specimens were cut to produce 
approximately 2 × 2 × 2 mm beams using a diamond disk and processed according to the 
standard TEM protocols as described below: 
1. Fixation: specimens were fixed in fixative (Karnovsky) for 24 h and rinsed in 0.1 
M sodium cacodylate buffer for ½ h. 
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2. Post-fixation: specimens were placed in 1% osmium tetroxide in 0.1 M sodium 
cacodylate buffer (pH 7) at room temperature for 1 h followed by rinsing with 0.1 
M sodium cacodylate buffer (pH=7) for ½ h. 
3. Dehydration: specimens were dehydrated in ascending concentrations of ethanol: 
30%, 50%, 70%, 85%, 90%, and 100% (1 h for each concentration) 
4. First infiltration/embedding: dehydrated specimens were infiltrated with 100% 
propylene oxide, 1:1, 1:2 and 1:3 of 100% propylene oxide, and 100% embedding 
resin at room temperature (1 h each), respectively. 
5. Dehydrated specimens were embedded in resin and polymerized for 48 h at 60°C. 
6. The resin blocks were first thick sectioned at 1–2 microns with glass knives using 
an Ultracut UCT (Leica, Bannockburn, IL). These sections were used as a 
reference to trim blocks for thin sectioning. 
7. The resin blocks were thin sectioned using a diamond knife (Diatome, Electron 
Microscopy Sciences, Hatfield, PA) at 70–90 nm thick (silver to pale gold using 
color interference). The sections were then placed on copper mesh grids.  
8. After drying on filter paper for a minimum of 1 hour, the sections were examined 
using a transmission electron microscope Tecnai BioTwin (FEI, Hillsboro, OR, 
USA).  
Statistical analysis 
Data were analyzed using One-way Analysis of Variance (ANOVA) followed by 
Tukey’s test for multiple comparisons. A significance level was set at α=0.05. Results 
were summarized as the mean and standard deviation. 
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RESULTS 
Specific aim 1 
Degree of conversion 
Table 2 and Figure 7 show the results of degree of conversion of the control 
(SBMP) and modified adhesives that were polymerized for 10 sec, 20 sec,or 40 sec. 
Generally, increasing the curing times increased the degree of conversion: 60.68–64.10% 
(10 sec), 63.74–69.70% (20 sec), and 70.79–72.62% (40 sec). However, no statistically 
significant differences in the degree of conversion were found (p > 0.05) with each curing 
time between the modified adhesives and the control (SBMP). 
Agar diffusion test 
Representative images of agar diffusion test of control (SBMP) and modified 
adhesive disks against S. mutans at 72 h of incubation are shown in Figure 8. No growth 
inhibition was observed for the control (SBMP, Figure 8A) and HNT (Figure 8B). The 
mean inhibition zone of 10% DOX adhesive disks was 12.0 ± 0.0 mm (Figure 8C). The 
results indicated successful encapsulation and release of DOX from the modified 
adhesive (10% DOX). The mean inhibition zone of 0.12% chlorhexidine (positive 
control, Figure 8D) was 21.0 ± 1.0 mm and no inhibition was seen with sterile PBS 
(negative control). 
Eluates from control (SBMP), HNT, and 10% DOX adhesive disks incubated up 
to 14 days in PBS did not inhibit bacterial growth (data not shown).  
Cytocompatibility 
Cytotoxicity of adhesive eluates from specimen disks tested on human dental pulp 
stem cells (hDPSCs, Figure 9) showed no significant differences (p = 0.225) among 
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groups and dilutions tested compared to the control (100% survival, no adhesive eluates, 
p > 0.05). Human DPSC viability ranged from 92.0–107.8% indicating no toxicity of the 
adhesive eluates to hDPSCs. 
MMP mediated casein cleavage assays 
MMP mediated casein cleavage assays (Figure 10) demonstrated that doxycycline 
containing eluates from 14 days (10% DOX) inhibited 13.4% of the MMP-1 activity 
compared to 48% by 0.1% DOX (positive control). Conversely, the eluates from days 1 
and 7 (10% DOX) showed 0% inhibition, whereas eluates from HNT modified adhesives 
ranged from 0–1.8% inhibition.  
Microtensile bond strength and failure mode analysis 
Mean microtensile bond strengths (Table 3) were 44.6 ± 15.2 MPa (HNT), 51.7 ± 
23.3 MPa (SBMP), and 54.3 ± 19.1 MPa (10% DOX). Statistical analysis revealed no 
significant differences in microtensile bond strengths among the groups (p = 0.07). The 
modes of failure were predominantly mixed (52.78–60.98%, Table 3) followed by 
adhesive failure (23.26–31.71%), cohesive failure in resin composite (2.44–19.44%), and 
cohesive failure in dentin (2.78–11.63%). 
Scanning electron microscopy (SEM) analysis 
Representative SEM micrographs of the fractured surfaces are shown in Figure 
11. At high magnification, rod-like structures indicating the presence of halloysite 
nanotubes were found in HNT group (Figure 11A, 11B) and 10% DOX (Figure 11C, 
11D). 
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Specific aim 2 
Encapsulation efficiency and drug loading 
Results of doxycycline encapsulation determined by HPLC and by dry weight are 
shown in Table 4 and Table 5, respectively. As determined by HPLC (Table 4), the 
doxycycline that was encapsulated into HNT was 0.24 ± 0.00 g for 10% DOX, 0.36 ± 
0.01 g for 20% DOX, and 0.47 ± 0.02 g for 30% DOX. The encapsulation efficiency was 
47.08 ± 1.68% for 10% DOX, 36.24 ± 0.54% for 20% DOX, and 31.54 ± 1.05% for 30% 
DOX. The drug loading (DOX: HNT ratio) was 19.17 ± 0.28% for 10% DOX, 29.05 ± 
0.48% for 20% DOX, and 37.85 ± 1.27% for 30% DOX. Statistical analyses revealed 
significant differences in the amount of encapsulated doxycycline, encapsulation 
efficiency, and drug loading among the three groups (p < 0.001). 
As determined by dry weight (Table 5), the doxycycline that was encapsulated 
into HNT was 0.18 ± 0.01 g for 10% DOX, 0.28 ± 0.01 g for 20% DOX, and 0.37 ± 0.02 
g for 30% DOX. The encapsulation efficiency was 34.73 ± 1.93% for 10% DOX, 27.46 ± 
1.43% for 20% DOX, 24.74 ± 1.39% for 30% DOX. The drug loading (DOX: HNT ratio) 
was 14.16 ± 0.90% for 10% DOX, 22.02 ± 1.17% for 10% DOX, and 29.70 ± 1.67% for 
10% DOX. One-way ANOVA showed no significant differences in the amount of 
encapsulated doxycycline, encapsulation efficiency, and drug loading among the three 
groups (p < 0.001). 
The results of doxycycline encapsulation determined by both techniques showed a 
similar trend. Generally, the increases in the concentration of doxycycline significantly 
increased the amount of doxycycline that was encapsulated into HNT and drug loading 
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into the HNT. On the other hand, the increases in the concentration of doxycycline 
significantly decreased the encapsulation efficiency. 
Degree of conversion 
The degree of conversion of control (SBMP) and modified adhesives that were 
polymerized for 10 sec, 20 sec or 40 sec is shown in Table 6 and Figure 12. Increasing 
curing times led to an increase in the degree of conversion: 61.40–64.68 % (10 sec), 
64.15–68.65 % (20 sec), and 70.44–73.26 % (40 sec). No significant differences were 
found with each curing time between each of the modified adhesives and the control 
(SBMP, p > 0.05).  
Knoop microhardness  
Results of Knoop microhardness of control (SBMP) and modified adhesives are 
shown in Figure 13. The Knoop microhardness values were 20.72 ± 1.38 (SBMP), 21.21 
± 0.59 (HNT), 22.18 ± 0.97 (10% DOX), 21.87 ± 2.28 (20% DOX), and 20.89 ± 1.30 
(30% DOX). No significant differences were found among the groups (p > 0.05).  
Amount of doxycycline in adhesive disks 
Table 7 shows the amount of doxycycline in one adhesive disk determined by 
mass spectrometry. When specimen disks were dissolved in DMSO, the doxycycline 
contents in one modified adhesive disk were 0.11 ± 0.16 µg (control, SBMP), 0.06 ± 0.08 
µg (HNT), 292.51 ± 29.77 µg (10% DOX), 911.06 ± 48.20 µg (20% DOX), and 1644.17 
± 40.71 µg (30% DOX). When 7.5 mg of DOX-encapsulated HNT powder was dissolved 
in ethanol, the doxycycline content in one modified adhesive disk were 234.26 ± 11.31 
µg (10% DOX), 846.15 ± 43.88 µg (20% DOX), and 1485.35 ± 115.88 µg (30% DOX).  
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Doxycycline release profiles 
Table 8 and Figure 14 show the cumulative release of doxycycline from the 
control (SBMP) and modified adhesives over 28 days. Generally, the release of 
doxycycline from the control (SBMP) and modified adhesive disks had an initial burst at 
24 h and gradually decreased overtime.  The cumulative release of doxycycline (mean ± 
SE) from the adhesive over 28 days was 0.55 ± 0.00 µg (SBMP), 0.59 ± 0.01 µg (HNT), 
4.04 ± 0.05 µg (10% DOX), 4.79 ± 0.07 µg (20% DOX), and 8.21 ± 0.088 µg (30% 
DOX). No significant differences in total cumulative doxycycline release were found 
among 10% DOX, 20% DOX, and 30% DOX (p = 0.259). 
Amount of doxycycline in adhesive disks after 4 months 
The amounts of doxycycline that remained in adhesive disks are shown in Table 
9. The amounts were 39.77 ± 0.78 µg (10% DOX), 55.50 ± 10.97 µg (20% DOX), and 
102.63 ± 11.71 µg (30% DOX). Compared to the original amounts of doxycycline, the 
percent of doxycycline that remained in an adhesive disk were 13.60% (10% DOX), 
6.09% (20% DOX), and 6.24% (30% DOX), respectively. 
Agar diffusion test 
Agar diffusion test was performed on two main pathogens of dental caries (S. 
mutans and L. casei). Figure 15 shows representative images of agar diffusion at 72 h of 
incubation.  
The inhibition zones for S. mutans (Table 10) were 2.3 ± 3.6 mm (10% DOX), 8.1 
± 0.9 mm (20% DOX), 11.5 ± 2.6 mm (30% DOX), and 16.0 ± 1.1 mm (0.12% 
chlorhexidine, positive control). The inhibition zones for L. casei (Table 10) were 5.1 ± 
4.0 mm (10% DOX), 7.2 ± 3.7 mm (20% DOX), 11.3 ± 1.8 mm (30% DOX), and 14.4 ± 
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0.5 mm (0.12% chlorhexidine, positive control). No inhibition zones were observed for 
sterile PBS (negative control), SBMP, and HNT.  
Figure 16 shows representative images for the agar diffusion test for doxycycline 
containing eluates of control (SBMP) and modified adhesive disks against S. mutans and 
L. casei at 72 h of incubation. The doxycycline containing eluates of 28 days of 
incubation did not inhibit the growth of either bacterial strain.  These results indicated 
that the amount of doxycycline released from the modified adhesives were 
subantimicrobial levels (below the minimum inhibitory concentration).  
FITC labeled type I collagen cleavage assay 
Figure 17 shows representative images of Western blotting of inactive pro-MMP-
1 and APMA activated MMP-1. The western blot results confirmed the activation of pro-
MMP-1 by AMPA. The active MMP-1 is approximately 10 kDa smaller than the inactive 
forms. FITC labeled type I collagen cleavage assay demonstrated inhibition of MMP-1 
activity by doxycycline containing eluates (Table 11 and Figure 18). Generally, the 
degree of MMP inhibition was the highest by doxycycline containing eluates from day 1 
and gradually decreased overtime. 0.1% doxycycline (positive control) inhibited 44.11 ± 
2.28% of MMP-1 activity. Doxycycline containing eluates from day 1 inhibited 16.20 ± 
8.09% (10% DOX), 23.61 ± 3.33% (20% DOX), and 26.33 ± 5.01% (30% DOX) of 
MMP-1 activity. Inhibitions decreased to 3.05 ± 3.05% (10% DOX), 2.39 ± 2.39% (20% 
DOX), and 3.76 ± 1.46% (30% DOX) for the day 28 eluates. Eluates from the control 
(SBMP) and HNT inhibited 2.65–4.92 % (SBMP) and 1.27–8.88 % (HNT) of MMP-1 
activity. Statistical analysis showed that there were significant differences between 0.1% 
doxycycline and all groups for all time points. At day 1, eluates of 30% DOX showed 
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significantly higher MMP inhibition than control (SBMP, p < 0.05). At day 7, eluates of 
10% DOX and 30% DOX showed significantly higher MMP inhibition than control 
(SBMP) and HNT (p < 0.05). No other significant differences were found (p > 0.05). 
Cytocompatibility 
Figure 19 shows hDPSC viability (%) when exposed to eluates obtained from 
control (SBMP) and modified adhesive disks. The viability of hDPSCs incubated with 
various eluates ranged from 81.60% to 107.92% compared with that of cells that were not 
incubated with eluates (100% survival). The hDPSCs incubated with 0.3% phenol, which 
served as the negative control (total cell death), showed 0% viability. No significant 
differences were found among cells incubated with eluates of the same dilution of each 
group of samples compared with cells that were not incubated with eluate (100% 
survival, p > 0.05). 
Transmission electron microscopy (TEM)  
Representative TEM micrographs of the interface between resin composite and 
HNT modified adhesive are shown in Figure 20. Small clusters of HNT were observed at 
the interface between resin composite and HNT modified adhesive (Figure 20A and 
20B). Conversely, HNT was not found in control (SBMP). Fillers of the resin composite 
were only found along the interface in control (SBMP, Figure 20C and 20D). 
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DISCUSSION 
Over the past few years, MMPs have been shown to play a major role in hybrid 
layer degradation. Several approaches have been proposed to inhibit MMP activity within 
the hybrid layer such as using MMP inhibitors (Almahdy et al., 2012; Breschi et al., 
2010) and chelating agents (chlorhexidine) (Carrilho et al., 2007; Ricci et al., 2010; 
Stanislawczuk et al., 2014). This study is a proof of concept that doxycycline, an MMP 
inhibitor, could be encapsulated into aluminosilicate clay nanotubes (HNT) and the 
doxycycline released overtime could inhibit MMP activity. Doxycycline was chosen in 
this study because it is the only MMP inhibitor that is approved by the FDA and 
subantimicrobial doses of doxycycline have been widely used as an adjunctive systemic 
therapy for periodontal disease (Giannobile, 2008). HNT was used as a drug carrier in 
this study because it has been used for drug encapsulation for controlled release of many 
drugs and other agents [e.g., tetracycline (Qi et al., 2013), dexamethasone (Veerabadran 
et al., 2009), Nifedipine and Furosemide (Lvov et al., 2008)]. Furthermore, HNT is safe, 
biocompatible and has high mechanical strength. Therefore, the use of doxycycline by 
encapsulating it into HNT would provide a sustained release for MMP inhibition. 
Furthermore, the mechanical properties of the dental adhesive loaded with HNT would 
not be compromised due to the high strength of HNT (Bottino et al., 2013). 
This study was conducted with two specific aims. The first specific aim focused 
mainly on the potential use of doxycycline for MMP inhibition in the hybrid layer and its 
effects on the immediate resin-dentin microtensile bond strength. The concentration of 
doxycycline used for encapsulation was 10% (w/v). The data suggested that the 
concentration of doxycycline that was encapsulated into HNT and then incorporated into 
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the dental adhesive reached the minimum inhibitory concentration (MIC, 0.25–0.50 
mg/mL (Al-Ahmad et al., 2014) and inhibited the growth of S. mutans when the 
specimen disks were directly contacting the bacteria. This result indicated successful 
encapsulation of doxycycline into HNT. On the other hand, the eluates containing 
doxycycline released from modified adhesive disks did not inhibit the growth of S. 
mutans but inhibited 13.4% of the MMP-1 activity (day 14 eluates). The results from 
antibacterial and anti-MMP activity led to the conclusion that doxycycline released from 
modified adhesive disks was at subantimicrobial levels. 
It is very important to know the effects of doxycycline on monomer conversion of 
the adhesive because the incorporation of doxycycline led to significant darkening of the 
adhesives. This study investigated the degree of conversion of the modified adhesives by 
curing them not only for 10 sec as recommended by manufacturer, but also for 20 sec and 
40 sec. Results showed no significant impact (p > 0.05) of different concentrations of 
doxycycline on monomer conversion when the specimens were polymerized with the 
same curing time between the modified adhesives and the control (SBMP). Furthermore, 
the release of doxycycline was not due to underpolymerization.  
Regarding the resin-dentin microtensile bond strength, the incorporation of either 
HNT or DOX-encapsulated HNT did not jeopardize microtensile bond strength as no 
significant differences were found (p = 0.07). This finding was supported by a previously 
published study that the incorporation of HNT at 15% (w/v) did not increase nor 
compromise the resin-dentin bond strength (Bottino et al., 2013). This is because the 
degree of conversion of the modified adhesives was not jeopardized by the incorporation 
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of doxycycline. SEM micrographs confirmed the presence of HNT in the hybrid layer 
(Figure 11).  
In conclusion, the results of the first specific aim established successful 
encapsulation and release of doxycycline from modified adhesives at subantimicrobial 
levels. Furthermore, the resin-dentin bonding was not compromised by the use of 
doxycycline. However, the amount of doxycycline that was encapsulated into HNT and 
the amount of doxycycline-released from the modified adhesives were unknown. These 
limitations were evaluated in specific aim 2.  
Specific aim 2 was focused on the encapsulation of various concentrations of 
doxycycline (10–30%, w/v). The amount of doxycycline released and encapsulated into 
the HNT was also determined. In this part, drug encapsulation was evaluated by both 
HPLC and dry weight. The results from both techniques are in agreement with each other 
that increased concentrations of doxycycline significantly increased the amount of 
doxycycline that was encapsulated into the HNT. Conversely, higher concentrations of 
doxycycline significantly decreased the encapsulation efficiency. This reduction is 
possibly due to the threshold limit because the amount of HNT used for the encapsulation 
was constant (1.25 g of HNT in 5 mL of doxycycline solution) regardless of the 
concentration of doxycycline used. A study conducted by Qi et al reported a similar trend 
when HNT was encapsulated by tetracycline (Qi et al., 2010).  
Since HNT is positively charged on the inner surface and negatively charged on 
the outer surface, the driving force for drug encapsulation on the surfaces of HNT could 
possibly be due to the differences in charges between the cationic drug (i.e., doxycycline) 
(Seleem et al., 2009) and the negatively charged HNT. Moreover, when vacuum is 
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applied, doxycycline could be pushed into the lumen of HNT due to the negative pressure 
regardless of the charge of the materials. 
Regarding the physico-chemical properties of modified adhesives, one-way 
ANOVA revealed no statistically significant differences between the modified adhesives 
compared to the control (SBMP) when tested with the same curing time. Nevertheless, it 
is important to point out that even though doxycycline incorporation led to a darker 
adhesive, it did not compromise resin monomer conversion. Therefore, these modified 
adhesives could potentially be handled and used in the same fashion as the commercial 
ones. This study further evaluated the Knoop microhardness of each of the modified 
adhesives with the same dimension as that used for drug release profile (6.2 mm × 1 mm) 
by curing specimens for 20 sec (each side) to ensure that the polymerization of modified 
adhesives is not compromised due to thicker specimens. Moreover, it was reported that 
there is a strong correlation (r2 > 0.9) between the degree of conversion and 
microhardness (Ferracane, 1985). Statistical analysis showed no significant differences 
among the groups. These results suggested that curing the modified adhesives would not 
jeopardize monomer conversion. Therefore, the release of doxycycline was not due to 
undercuring of the adhesives. 
Regarding the release profile of doxycycline from modified adhesives, higher 
concentrations of doxycycline led to higher release of doxycycline from the modified 
adhesives although no significant differences (p = 0.259) were found among groups 
(10%, 20% and 30% DOX). Although higher concentration of doxycycline (> 30%, w/v) 
could provide higher release, the concentration used in this study was limited by the 
solubility and the pH of doxycycline that was dissolved in 50 mM HEPES (pH 7.2). 
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Doxycycline was not completely dissolved in 50 mM HEPES with a concentration higher 
than 30% (w/v). Moreover, the increased concentration of doxycycline significantly 
decreased pH of the doxycycline solution (i.e., pH of 30% DOX solution was 
approximately 3.5 whereas pH of 50% DOX was approximately 1). Since the pH of the 
dental adhesive (SBMP) is approximately 3.5–4.0, the increased concentration of 
doxycycline could significantly drop pH of the modified adhesive leading to changes in 
the properties of the adhesive or interactions between adhesive and demineralized dentin. 
The cumulative release of doxycycline over 28 days was approximately 1–2% of 
the amount of doxycycline in the adhesive disks. Therefore, the doxycycline remaining in 
the adhesive disks would serve as a reservoir for sustained release over time. After 4 
months of incubation, the doxycycline left in the adhesive was approximately 6–13% of 
the original concentration. Theoretically, most doxycycline should remain in the adhesive 
or almost all of the doxycycline should be released into the incubation medium. 
However, a portion of the doxycycline was lost during the incubation. This is possibly 
due to the half-life of the doxycycline that was reported to be approximately 24 h in vivo 
or in cell culture media (Centlivre et al., 2010; Strickman et al., 1995; Wang et al., 2003). 
It is important to point out that doxycycline was encapsulated in HNT and the DOX-
encapsulated HNT was used for adhesive fabrication. In other words, doxycycline was in 
the solid form in adhesive disks. This condition should protect doxycycline from 
degradation. 
As expected, results of agar diffusion tests revealed successful incorporation of 
DOX-encapsulated HNT into modified adhesives. The modified adhesive disks inhibited 
the growth of both S. mutans and L. casei. Overall, higher concentrations of doxycycline 
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showed larger inhibition zones. Conversely, the doxycycline containing eluates of 28 
days of incubation did not inhibit the growth of either bacterial strain. This result 
indicated that the concentration of doxycycline released from the specimens was below 
the minimum inhibitory concentration (S. mutans = 0.25–0.50 mg/mL and L. casei = 
0.38–1.5 mg/mL (Al-Ahmad et al., 2014). In other words, the eluates obtained from 
DOX-encapsulated specimens contained subantimicrobial levels of doxycycline. 
To evaluate anti-MMP properties of doxycycline containing eluates, an FITC 
labeled type I collagen was used as the substrate for MMP-1. MMP-1 was used in this 
study because only MMP-1, MMP-8 and MMP-13 are true collagenases and can cleave 
fibrillar collagen more efficiently than the other types of MMPs. Furthermore, MMP-1 is 
also found in dentin along with MMP-2, MMP-3, MMP-8, and MMP -9 (Sulkala et al., 
2007; van Strijp et al., 2003; Wang et al., 2012). The results demonstrated MMP-1 
inhibition by the doxycycline containing eluates. Overall, doxycycline containing eluates 
from day 1 showed the highest MMP inhibition (16.20–26.33%), and the degree of 
MMP-1 inhibition by doxycycline containing eluates gradually decreased overtime 
compared to the negative control (Tris buffer). The positive control (0.1% doxycycline) 
inhibited 44.11 % of MMP-1 activity that was significantly higher than all other groups. 
This led to the conclusion that doxycycline was released from specimen disks at 
subantimicrobial levels. TEM micrographs of the interface between resin composite and 
the modified adhesive (Figure 20) showed the presence of small clusters of HNT, similar 
to SEM images of the fracture surfaces of the microtensile beams (Figure 11, specific aim 
1). This finding indicated that HNT could serve as a reservoir for drug release.  
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Cytocompatibility tests revealed that the viability of hDPSCs cultured in 
doxycycline containing eluates ranged from 81.60% to 107.92%, compared to those 
cultured without eluate (100% survival). This is considered as slight toxicity (60–90% 
cell viability) or non-cytotoxicity (>90% cell viability) according to Dahl et al. (Dahl et 
al., 2006).  
These findings led to the conclusion that doxycycline containing eluates had 
subantimicrobial properties and the ability to inhibit MMPs without toxicity and without 
compromising the physico-chemical properties of the adhesives. However, this study 
lacks the information regarding the resin-dentin bond strength especially the immediate 
bond strength of modified adhesives at 20% DOX and 30% DOX. Since the degree of 
conversion of the modified adhesives was not compromised by the incorporation of 
DOX-encapsulated HNT, the immediate dentin bond strength should not significantly 
decrease compared to the control (SBMP). Moreover, the data from specific aim 1 
showed that the adhesive modified with 10% DOX-encapsulated HNT did not 
significantly decrease the microtensile bond strength to dentin evaluated after 24 h of 
bonding (Feitosa et al., 2014). Nevertheless, it would be informational to further 
investigate the immediate and the long-term bond durability of the resin-dentin bonding 
using the microtensile bond strength test along with nanoleakage and TEM studies of the 
resin-dentin interface after aging (i.e., 6 months or 1 year). Furthermore, the other MMP 
inhibitors, such as epigallocatechin gallate (EGCG), that do not change the color of the 
adhesive and are more stable in the oral environment, should be investigated. 
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SUMMARY AND CONCLUSIONS 
The ultimate goal of this project was to evaluate doxycycline for its effects on 
preventing the degradation of hybrid layer through the modification of dental adhesive 
with aluminosilicate clay nanotubes (HNT) loaded with doxycycline. Doxycycline was 
chosen because it is an MMP inhibitor that is approved by the Food and Drug 
Administration (FDA). Doxycycline was encapsulated into HNT at three distinct 
concentrations (10%, 20% and 30% DOX, w/v). The increases in the concentration of 
doxycycline significantly increased the amount of doxycycline that was encapsulated into 
HNT and the drug loading into HNT. Conversely, the encapsulation efficiency was 
significantly decreased with increasing concentrations of doxycycline. The modified 
adhesives were fabricated by incorporation of DOX-encapsulated HNT into a 
commercially available three-step etch-and-rinse dental adhesive (Adper Scotchbond 
Multi-Purpose). The degree of conversion, Knoop microhardness, doxycycline release 
profiles, the biological activity (antibacterial and anti-MMP activity), and 
cytocompatibility of the modified adhesives were investigated. There were no statistically 
significant differences (p > 0.05) in the degree of conversion and Knoop microhardness 
compared to the control (SBMP). None of the adhesives eluates was cytotoxic to the 
human dental pulp stem cells. Higher concentrations of doxycycline led to generally 
higher release of doxycycline from the modified adhesives, although no significant 
differences (p = 0.259) were found among the groups (10%, 20% and 30% DOX). A 
significant growth inhibition of S. mutans and L. casei by direct contact illustrated 
successful encapsulation of doxycycline into the modified adhesives. Doxycycline 
released from the modified adhesives (doxycycline containing eluates) did not inhibit the 
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growth of both cariogenic bacteria but inhibited MMP-1 activity. The results suggested 
subantimicrobial levels of doxycycline were released. The immediate microtensile bond 
strengths were not significantly different compared to the control (SBMP) suggesting no 
negative effects of doxycycline on dentin bonding (only 10% DOX was investigated).  
Collectively, the results suggested that HNT could be used as a drug carrier for 
release of doxycycline and possibly other MMP inhibitors without compromising the 
physico-chemical properties of modified adhesives or toxic effects to the human cells. 
This study lacks information regarding the long-term resin-dentin bond durability (i.e, 6 
months or 1 year bond strength). However, it provides a solid background for the use of 
other MMP inhibitors that do not change the color of the adhesive and are more stable in 
the oral environment. 
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TABLES 
Table 1. Classification of matrix metalloproteinases (MMPs). 
Subgroup  
Collagenases MMP-1, MMP-8, MMP-13, and MMP-18 
Gelatinases MMP-2 and MMP-9 
Stromelysins MMP-3, MMP-10, and MMP-11  
Matrilysins MMP-7, and MMP-26 
Membrane-type 
MMPs 
MMP-14, MMP-15, MMP-16, MMP-17, MMP-24, and 
MMP-25 
Others 
MMP-12, MMP-19, MMP-20, MMP-21, MMP-23, 
MMP- 27, and MMP-28 
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Table 2. Degree of conversion of control (SBMP) and the modified adhesives that were 
polymerized for 10 sec, 20 sec or 40 sec. 
Group 
Degree of conversion (%) 
10 sec 20 sec 40 sec 
SBMP 62.67 ± 2.74 63.74 ± 5.38 72.62 ± 1.72 
HNT 64.10 ± 5.43 65.72 ± 4.33 70.79 ± 1.93 
10% DOX 60.68 ± 4.51 69.70 ± 3.93 72.62 ± 5.89 
The energies applied during light curing of 10 sec, 20 sec and 40 sec were 10.92 J/cm2, 
22.49 J/cm2 and 46.18 J/cm2, respectively. No statistically significant differences were 
found (p > 0.05) with each curing time between the modified adhesives and the control 
(SBMP). 
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Table 3. Mean microtensile bond strength (µTBS, mean ± SD) and failure modes. 
Group 
µTBS 
(MPa) 
Failure modes (%) 
Adhesive Mixed Cohesive-dentin 
Cohesive-
resin 
SBMP 51.7 ± 23.3 25.00 52.78 2.78 19.44 
HNT 44.6 ± 15.2 31.71 60.98 4.88 2.44 
10% DOX 54.3 ± 19.1 23.26 53.49 11.63 11.63 
Microtensile bond strengths showed no statistically significant differences among the 
groups (p = 0.07).  
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Table 4. Encapsulation of doxycycline determined by HPLC. 
Group 
Un-encapsulated 
DOX (g) 
Encapsulated 
DOX (g) 
Encapsulation 
efficiency (%) 
Drug Loading 
(%) 
10% DOX 0.26 ± 0.00 0.24 ± 0.00 47.08 ± 1.68 19.17 ± 0.28 
20% DOX 0.64 ± 0.01 0.36 ± 0.01 36.24 ± 0.54 29.05 ± 0.48 
30% DOX 1.03 ± 0.02 0.47 ± 0.02 31.54 ± 1.05 37.85 ± 1.27 
There was a significant difference (p < 0.001) in the amount of encapsulated doxycycline, 
encapsulation efficiency and drug loading among the 3 concentrations of doxycycline. 
The amount of doxycycline used for encapsulation was 0.5 g (10% DOX), 1.0 g (20% 
DOX) and 1.5 g (30% DOX). Drug loading (DOX:HNT) is the ratio between 
encapsulated doxycycline and added HNT (1.25 g). 
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Table 5. Encapsulation of doxycycline determined by dry weight. 
Group 
Un-encapsulated 
DOX (g) 
Encapsulated 
DOX (g) 
Encapsulatio
n efficiency 
(%) 
Drug Loading 
(%) 
10% DOX 0.32 ± .01 0.18 ± 0.01 34.73 ± 1.93 14.16 ± 0.90 
20% DOX 0.72 ± .02 0.28 ± 0.01 27.46 ± 1.43 22.02 ± 1.17 
30% DOX 1.12 ± 0.02 0.37 ± 0.02 24.74 ± 1.39 29.70 ± 1.67 
There was a significant difference (p < 0.001) in the amount of encapsulated doxycycline, 
encapsulation efficiency and drug loading among the 3 concentrations of doxycycline. 
The amount of doxycycline used for encapsulation was 0.5 g (10% DOX), 1.0 g (20% 
DOX) and 1.5 g (30% DOX). Drug loading (DOX:HNT) is the ratio between 
encapsulated doxycycline and added HNT (1.25 g). 
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Table 6. Degree of conversion of control (SBMP) and modified adhesives that were 
polymerized for 10 sec, 20 sec or 40 sec. 
Group 
Degree of conversion (%) 
10 sec 20 sec 40 sec 
SBMP 64.68 ± 3.35 68.20 ± 1.19 70.61 ± 1.42 
HNT 64.12 ± 2.80 66.93 ± 3.63 70.44 ± 1.16 
10% DOX 61.40 ± 3.07 64.15 ± 3.08 73.26 ± 3.21 
20% DOX 64.15 ± 3.09 66.19 ± 4.97 71.79 ± 4.16 
30% DOX 62.31 ± 4.86 68.65 ± 4.71 72.03 ± 2.25 
The energies applied during light curing of 10 sec, 20 sec and 40 sec were 10.92 J/cm2, 
22.49 J/cm2 and 46.18 J/cm2, respectively. No significant differences were found with 
each curing time between the modified adhesives and SBMP (p > 0.05).  
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Table 7. Amount of doxycycline (µg, mean ± SD) that was incorporated into the 
modified adhesive disks determined by two techniques. 
Group 
Doxycycline in the adhesive disk determined by 
Adhesive disk dissolved  
in DMSO (µg) 
7.5 mg DOX-encapsulated HNT 
powder dissolved in ethanol (µg) 
SBMP 0.11 ± 0.16 N/A 
HNT 0.06 ± 0.08 N/A 
10% DOX 292.51 ± 29.77 234.26 ± 11.31 
20% DOX 911.06 ± 48.20 846.15 ± 43.88 
30% DOX 1644.17 ± 40.71 1485.35 ± 115.88 
7.5 mg of DOX-encapsulated HNT powder was calculated based on the fact that an 
adhesive disk needs approximately 50 µL of modified adhesive solution. DOX-
encapsulated HNT powder was mixed with the adhesive solution at 15% (w/v, 150 mg in 
1 mL of adhesive solution). Therefore, 50 µL of modified adhesive solution had 
approximately 7.5 mg of DOX-encapsulated HNT powder. 
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Table 8. Cumulative release profile (µg, mean ± SE) of control (SBMP) and modified 
adhesives determined by mass spectrometry. 
Groups 
Cumulative release of doxycycline (µg) 
Day 1 Day 7 Day 14 Day 21 Day 28 
SBMP 0.19 ± 0.02 0.30 ± 0.01 0.39 ± 0.00 0.47 ± 0.00 0.55 ± 0.00 
HNT 0.24 ± 0.01 0.34 ± 0.02 0.42 ± 0.02 0.50 ± 0.01 0.59 ± 0.01 
10% DOX 1.71 ± 0.45 2.69 ± 0.19 3.29 ±0.09 3.70 ± 0.06 4.04 ± 0.05 
20% DOX 2.30 ± 0.55 3.26 ± 0.20 2.94 ± 0.13 4.41 ± 0.09 4.79 ± 0.07 
30% DOX 4.81 ± 1.96 6.38 ± 0.51 7.24 ± 0.23 7.80 ± 0.14 8.21 ± 0.08 
No significant differences in total cumulative doxycycline release were found among 
10% DOX, 20% DOX, and 30% DOX (p = 0.259).  
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Table 9. Amount of doxycycline remaining in modified adhesive disks after 4 months of 
incubation in phosphate buffer saline (PBS). 
Group 
DOX remaining in  
adhesive disk (µg) 
Percent remaining 
(%) 
SBMP 0.15 ± 0.17 N/A 
HNT 1.60 ± 1.87 N/A 
10% DOX 39.77 ± 0.78 13.60 
20% DOX 55.50 ± 10.97 6.09 
30% DOX 102.63 ± 11.71 6.24 
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Table 10. Agar diffusion test of control (SBMP) and modified adhesive disks against S. 
mutans and L. casei at 72 h of incubation. 
 
Group 
Average inhibition zone (mm) 
S. mutans L. casei 
0.12% CHX 16.0 ± 1.1 14.4 ± 0.5 
10% DOX 2.3 ± 3.6 5.1 ± 4.0 
20% DOX 8.1 ± 0.9 7.2 ± 3.7 
30% DOX 11.5 ± 2.6 11.3 ± 1.8 
0.12% chlorhexidine (CHX) and sterile PBS were used as positive and negative controls, 
respectively. No inhibition zones were observed with SBMP, HNT and sterile PBS.  
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Table 11. Inhibition of MMP-1 by doxycycline (DOX) containing eluates (mean ± SE) 
compared with negative control (Tris buffer) and positive control (0.1% doxycycline 
solution). 
Group 
Inhibition by doxycycline containing eluates (%, mean ± SE) 
Day 1 Day 7 Day 14 Day 21 Day 28 
0.1% DOX 44.11 ± 2.28 
SBMP 3.99 ± 3.44 3.53 ± 2.74 2.65 ± 2.47 4.92 ± 2.08 2.86 ± 1.98 
HNT 8.88 ± 3.17 3.06 ± 3.06 4.32 ± 2.68 4.86 ± 2.55 1.27 ± 1.27 
10% DOX 16.20 ± 8.09 18.25 ± 1.78 8.39 ± 3.25 11.17 ± 2.61 3.05 ± 3.05 
20% DOX 23.61 ± 3.33 17.36 ± 2.08 14.68 ± 3.24 8.83 ± 1.01 2.39 ± 2.39 
30% DOX 26.33 ± 5.01 25.18 ± 1.49 15.10 ± 2.13 14.82 ± 3.41 3.76 ± 1.46 
Statistical analysis showed significant difference between 0.1% doxycycline and each 
sample at all time points (p < 0.05). At day 1, eluates of 30% DOX had significantly 
higher MMP inhibition than those of control (SBMP, p < 0.05). At day 7, eluates of 10% 
DOX and 30% DOX showed significantly higher MMP inhibition than those of control 
(SBMP) and HNT (p < 0.05). No significant differences were found with other samples 
(p > 0.05). The negative control (Tris buffer) was 50 mM Tris with 0.2 M NaCl, 10 mM 
CaCl2, and 1 µM ZnCl2, pH 7.4). 
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FIGURES 
 
Figure 1. Monomers commonly used in dental resin composites and dental adhesives. 
These monomers contain ester-linkages that are vulnerable to hydrolysis. 
 
  
  76 
 
 
Figure 2. Biodegradation of the dental monomer Bisphenol A glycidyl dimethacrylate 
(Bis-GMA) to Bis-hydroxy-propoxy-phenyl-propane (BisHPPP) and methacrylic acid 
(MA). 
 
  
  77 
 
Figure 3. Biodegradation of the dental monomer triethylene glycol dimethacrylate 
(TEGDMA) to triethylene glycol (TEG) and methacrylic acid (MA). 
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Figure 4. Activation of pro-MMPs by acid (H+) that reduces the bond between cysteine 
in the prodomain and Zn2+ in the catalytic domain of MMPs. 
 
  
Acid activation of 
pro-MMPs 
Active MMPs 
SH 
Catalytic domain 
Prodomai
n Hemopexin 
Cys Zn2+ 
OH 
H+ 
S 
Catalytic domain Hemopexin 
Zn2+ Cys 
Prodomain 
  79 
 
 
 
 
 
 
 
 
Figure 5. Chemical structure of doxycycline (C22H24N2O8). 
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Figure 6. Scanning electron micrograph at 20,000× (A) and Transmission electron 
micrograph at 68,000× (B, HV=80.0 kV, bar 100 nm) of aluminosilicate clay nanotubes 
(Halloysite, HNT, Dragonite 1415JM, Applied Minerals Inc., New York, NY, USA). 
 
  
(A) (B) 
100 nm 
  81 
 
Figure 7. Degree of conversion of control (SBMP) and modified adhesives that were 
polymerized for 10 sec, 20 sec or 40 sec. The energy applied during light curing of 10 
sec, 20 sec and 40 sec were 10.92 J/cm2, 22.49 J/cm2 and 46.18 J/cm2, respectively. 
Increasing curing times led to an increase in degree of conversion values: 60.7–64.1% 
(10 sec), 63.7–69.7% (20 sec), and 70.8–72.6% (40 sec). There were no statistically 
significant differences (p > 0.05) in degree of conversion with each curing time between 
each of the modified adhesives and the control (SBMP).  
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Figure 8. Representative macrophotographs of agar diffusion test of control (SBMP) and 
modified adhesive disks against S. mutans at 72 h of incubation. (A)  control (SBMP), 
(B) HNT, (C) 10% DOX, and (D) 0.12% chlorhexidine (positive control). Mean 
inhibition zones of 10% DOX and 0.12% chlorhexidine were 12.0 ± 0.0 mm and 21.0 ± 
1.0 mm, respectively. No inhibition zone was observed with control (SBMP) and HNT.  
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Figure 9. Cytotoxicity of eluates from control (SBMP) and modified adhesive specimens 
tested on human dental pulp stem cells (hDPSCs).  
No significant differences (p = 0.225) in cytotoxicity were found among all groups of 
study and dilutions tested. 
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Figure 10. Representative images of Coomassie blue stained SDS-PAGE gels of β-casein 
cleavage inhibition assays. (A) Negative control: 50 mM Tris with 0.2 M NaCl, 10 mM 
CaCl2, and 1 µM ZnCl2 (pH 7.4), (B) Positive control: 0.1% DOX solution (Sigma), (C) 
DOX-eluates (Day 1), (D) DOX-eluates (Day 7), and (E) DOX-eluates (Day 14). More β-
casein is present in Panel E compared to the negative control (50 mM Tris) at 2 hours. 
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Figure 11. Representative scanning electron micrographs of fractured microtensile 
beams. (A, B) HNT (100×, 5000×), (C, D) HNT+DOX (100×, 5000×). Arrows show rod-
like structure of approximately 1–2 µm in length indicating HNT incorporation into the 
modified adhesives. 
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Figure 12. Degree of conversion of control (SBMP) and modified adhesives that were 
polymerized for 10 sec, 20 sec or 40 sec. The energies applied during light curing of 10 
sec, 20 sec and 40 sec were 10.92 J/cm2, 22.49 J/cm2 and 46.18 J/cm2, respectively. 
Increasing curing times led to an increase in degree of conversion values: 61.40–64.68% 
(10 sec), 64.15–68.65% (20 sec), and 70.44–73.26% (40 sec). No significant difference 
was found with each curing time between each of the modified adhesives and SBMP (p > 
0.05).  
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Figure 13. Knoop microhardness number (KHN) of control (SBMP) and modified 
adhesives polymerized for 20 sec. KHN was 20.72 ± 1.38 (SBMP), 21.21 ± 0.59 (HNT), 
22.18 ± 0.97 (10% DOX), 21.87 ± 2.28 (20% DOX) and 20.89 ± 1.30 (30% DOX). No 
significant differences were found among groups of the study (p > 0.05).  
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Figure 14. Release profiles (mean ±	SE) of doxycycline of control (SBMP) and modified 
adhesives at day 1, 7, 14, 21, and 28. No significant differences in total cumulative 
doxycycline release were found among 10% DOX, 20% DOX, and 30% DOX (p = 
0.259). 
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Figure 15. Representative images of agar diffusion test of control (SBMP) and modified 
adhesive disks against S. mutans (left) and L. casei (right) at 72 h of incubation. The 
average inhibition zones on S. mutans were 16.0 ± 1.1 mm (0.12% chlorhexidine), 2.3 ± 
3.6 mm (10% DOX), 8.1 ± 0.9 mm (20% DOX), and 11.5 ± 2.6 mm (30% DOX). The 
average inhibition zones on L. casei were 14.4 ± 0.5 mm (0.12% chlorhexidine), 5.1 ± 4.0 
mm (10% DOX), 7.2 ± 3.7 mm (20% DOX), and 11.3 ± 1.8 mm (30% DOX). No 
inhibition zones were observed with SBMP, HNT, and sterile PBS. 0.12% chlorhexidine 
(CHX) and sterile PBS served as the positive and negative controls, respectively. 
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Figure 16. Representative images of agar diffusion test of adhesive disk eluates against 
S. mutans (left) and L. casei (right) at 72 h of incubation.  
The average inhibition zones of 0.12% chlorhexidine on S. mutans and L. casei were 15.5 
± 1.5 mm and 13.4 ± 1.6 mm, respectively. No inhibition zone was observed with other 
samples. 0.12% chlorhexidine (CHX) and sterile PBS served as the positive and negative 
controls, respectively. 
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Figure 17. Western blot analysis of unactivated MMP-1 (left) and APMA activated 
MMP-1 (right). 
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Figure 18. Inhibition of MMP-1 by doxycycline containing eluates (%, mean ± SE) 
compared to that by the negative control (Tris buffer), and the positive control (0.1% 
doxycycline solution). Statistical analysis showed significant difference between 0.1% 
doxycycline and each of the samples from various time points. At day 1, eluates of 30% 
DOX showed significantly higher MMP inhibition than those of control (SBMP, p < 
0.05). At day 7, eluates of 10% DOX and 30% DOX showed significantly higher MMP 
inhibition than those of control (SBMP) and HNT (p < 0.05). No other significant 
differences in MMP-1 inhibition among other eluates were found (p > 0.05). The 
negative control (Tris buffer) was 50 mM Tris with 0.2 M NaCl, 10 mM CaCl2, and 1 µM 
ZnCl2, pH 7.4). 
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Figure 19. Viability of human dental pulp stem cells (hDPSCs, %). hDPSCs were 
exposed to eluates of the control (SBMP) and modified adhesive disks. The viability of 
the cells incubated with various eluates ranged from 81.60% to 107.92% compared to 
that of the cells not incubated with eluate (100% survival). Cells incubated with 0.3% 
phenol serving as the negative control (total cell death) showed 0% viability. No 
significant differences were found among cells incubated with eluates of the same 
dilution of each group of samples compared with cells that were not incubated with 
eluates (100% survival, p > 0.05). 
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Figure 20. Transmission electron micrographs (HV=80kV) of the interface between resin 
composite and HNT modified adhesive at 20,000× (A), 120000× (B); and resin 
composite and SBMP at 18,500× (C), 98,000× (D). RC: Resin composite, AD: Dental 
adhesive, HNT: Halloysite nanotubes. 
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